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ABSTRACT
Aflatoxin, a mycotoxin, is one of the world’s most potent carcinogen. It 
contaminates major food products such as milk, grains, nuts, corn, etc., leading to greater 
than $ 1 billion in economic losses and when ingested causes hepatocellular carcinoma 
(HCC). It is the primary risk factor for 75% HCC cases in the developing world and 3% 
HCC cases in developed world. Most common methods used in agriculture to reduce 
aflatoxin contamination are expensive, time consuming and have low efficiency with 
limited success rates where as biological controls were proven to be most effective in 
inhibiting aflatoxins and aflatoxin producing fungi. Vibrio gazogenes, a non-pathogenic 
gram-negative marine bacterium, was proven to synthesize antifungal and antiaflatoxin 
metabolites. In this research study we have used Aspergillus parasiticus and Aspergillus 
flavus – two saprophytic pathogenic fungi as aflatoxin-producing models. Preliminary 
experimentation by treating V. gazogenes with aflatoxin produced aflatoxin responsive 
metabolites (ARMs) that had the ability to significantly decrease aflatoxin synthesis by 
inhibiting the aflatoxin genes (aflR, nor-1, ver-1) and global secondary metabolism genes 
(LaeA, VeA). But the decrease in aflatoxin was only 40%. So we treated the fungal 
cultures with the cells of V. gazogenes and the aflatoxin ELISAs revealed the significant 
decrease (>99%) in aflatoxin biosynthesis by the fungi. The aflatoxin inhibitory effect 
was very specific to V. gazogenes and not to other gram-positive or gram-negative 
bacterium. Infecting corn kernels with A. flavus in the presence of bacterium significantly 
decrease the fungal conidial growth by 50% and aflatoxin by 98%. Treating drosophila 
vi 
flies with V. gazogenes prior to A. flavus infection increased their survival. Using 
confocal, scanning electron and transmission electron microscopies we observed the 
uptake of the bacterium by the fungus into vesicles. RT-PCR assays revealed that live V. 
gazogenes cells significantly up-regulate aflatoxin genes (aflR, nor-1, ver-1) and global 
secondary metabolite genes (laeA, veA). The pathway through which V. gazogenes 
inhibits aflatoxin is complicating. But our study had clearly developed a novel tool (V. 
gazogenes) to inhibit the aflatoxin biosynthesis, which is acting at the cellular level rather 
than at the gene level. 
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CHAPTER 1 
INTRODUCTION
1.1 AFLATOXINS 
Aflatoxins are one of the most potent and dangerous carcinogens known 
worldwide (Schmale and Munkvold, 1998). They were discovered in the 1960s when 
100,000 turkeys died in Britain due to a toxin found in their peanut meal. The 
investigation led to the discovery of toxins secreted by Aspergillus flavus (Negash, 2018). 
The term aflatoxin is an acronym of Aspergillus flavus toxins (Brase S 2013). Aflatoxins 
are low molecular weight molecules of secondary metabolism produced by fungi 
belonging to the genus Aspergillus and Penicillium, during favorable growth conditions 
of oxygen, moisture (>7%), warm temperatures (24-35oC) and substrate (sugar) 
(Williams et al., 2004). Aflatoxins are a group of structurally related compounds 
consisting of 5 rings – a furofuran moiety, an aromatic ring, a lactone ring and either a 
pentanone or a lactone ring to complete the structure (Brase S 2013) (Figure 1.1). More 
than 20 known aflatoxins exists of which aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), 
aflatoxin G1 (AFG1), aflatoxin G2 (AFG2) are the primary aflatoxins and aflatoxin M1 
(AFM1) and aflatoxin M2 (AFM2) are the hydroxylated metabolites of AFB1 and AFB2 
(Kumar et al., 2016). 
According to the Chicago council on global affairs, 25% of all harvests in USA 
are contaminated by mycotoxins of which aflatoxin contamination of corn alone causes 
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losses at the high end of $1 billion (Mitchell et al., 2016). In the USA alone, the number 
of samples tested positive for aflatoxin increased 6% from 2012 to 2013. The FDA limits 
for aflatoxin human consumption is 20ppb, animal feeds is 300ppb and for aflatoxin M1 
in milk is 0.5ppb (FDA 2011). Aflatoxins contaminate crops, produce, food, nuts, cereal, 
milk, juices, homes, wood, etc., and can be ingested into intestines and enter systemic 
circulation. Depending on the amount of dose and length of period of intake, aflatoxin 
ingestion, inhalation or adsorption causes aflatoxicosis. Large doses for a short period of 
time lead to acute illness - abdominal pain, vomiting, enlarged liver, liver damage, fever, 
hemorrhage, pulmonary edema, digestive symptoms, convulsions etc. Chronic sub-lethal 
doses lead to immunologic suppression, decreased nutritional uptake, decreased growth 
and underweight in children and promoting liver cancers (Williams et al., 2004). 
Aflatoxin B1 has been categorized as class 1A human carcinogen by the International 
Agency of Research on Cancer (IARC) because it causes hepatocellular carcinoma. It is 
projected that 25,200-155,000 cases of liver cancer worldwide are attributed to aflatoxin 
exposure (Wu et al., 2011). 
Aflatoxin undergoes biotransformation primarily in the liver of both human and 
animal bodies producing a highly reactive epoxide that can bind to DNA, RNA, and 
proteins altering mitochondria structures and electron transport, effecting cell division 
and disrupting protein synthesis (Bbosa et al., 2013). Aflatoxin B1 can be passively 
absorbed through the intestines and is further metabolized by cytochrome P-450 
(CYP1A2, 3A4, 3A5, 3A7) enzymes in liver generating a mixture of metabolites of 
which aflatoxin-8,9-epoxide is highly reactive forming DNA adducts that are capable of 
GC to TA mutations inhibiting the tumor suppressor gene p53 (Bbosa et al., 2013) (Wu et 
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al., 2011) (Gratz et al., 2007) (Carlos A. Muro-Cach 2004). This p53 mutation had been 
observed in 30-60% of the liver cancers in aflatoxin-exposed cases. The reactive epoxide 
also binds to proteins in liver inhibiting them causing significant cellular damaging and 
acute aflatoxicosis in both humans and animals (REF). Aflatoxin also crosses placenta 
and is metabolized by the fetal CYP450 liver enzymes producing the same highly 
reactive epoxide. Thus aflatoxins are toxic, mutagenic, and carcinogenic (Bbosa et al., 
2013). 
1.2 Aspergillus flavus and Aspergillus parasiticus 
Aflatoxin is biosynthesized by many Aspergillus species such as A. flavus, A. 
parasiticus, A. nominus, A. pseutotamarii, A. bombycis, A. toxicarius, A. 
parvisclerotigenus, A. minisclerotigenes, A. arachidicola, and A. pseudocaelatus. But 
primarily aflatoxins are produced in copious amounts by A. flavus and A. parasiticus, 
which can cohabit and flourish on practically any crop or food including but not limiting 
to maize, oilseeds, spices, groundnuts, tree nuts, milk, and dried fruit (Strosnider et al. 
2006) (Varga et al., 2011). Aspergillus can also synthesize aflatoxin during postharvest 
handling of storage, transportation and food processing (Wu 2011). 
Aspergillus parasiticus is a soil mold that was discovered in 1912 by a pathologist 
A. T. Speare (Horn et al., 2009).  It is a saprophyte, a plant pathogen and an opportunistic 
pathogen to humans and animals and produces aflatoxins B1, B2, G1 and G2. 
The fungus Aspergillus flavus is a saprophyte, growing in humid environments 
with pathogenic ability causing aspergillosis in immuno-compromised humans effecting 
the skin, oral mucosa and subcutaneous tissues (Hedayati, et al. 2007: 1677-92). 
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According to the centers for disease control and prevention (CDC) approximately 4.8 
million cases of aspergillosis were diagnosed worldwide and A.flavus is the second most 
leading cause. A.flavus also infects corn, peanuts and cotton by releasing aflatoxins. 
Aflatoxin B1, an A.flavus secondary metabolite, has been categorized as class 1A human 
carcinogen by the International Agency of Research on Cancer (IARC) and contaminates 
crops, produce, food, nuts, cereal, milk, juices, homes, wood, etc., and can be ingested 
into intestines and enter systemic circulation causing aflatoxicosis and liver cancer. 
Most A.flavus strains are susceptible to antifungal therapy but the minimum 
inhibitory concentrations are atleast two fold higher than for other Aspergillus species 
(Krishnan, et al. 2009: 206-22). Furthermore, recent discoveries revealed the presence of 
active multi drug resistant genes in A.flavus strains increasing their potential for drug 
resistance and pathogenicity (Tobin, et al. 1997: 11-23) (Van Der Linden, et al. 2011: 
S82-9). Aflatoxin B1 synthesized by A.flavus is extremely stable and cannot be detoxified 
by cooking or autoclaving and thus pollutes many food groups being ingested by humans 
and animals. 
1.3 Vibrio gazogenes 
Most common methods used in agriculture to reduce aflatoxin contamination are 
expensive, time consuming and have low efficiency with limited success rates. Novel 
therapies are required to fight against A.flavus strains and inhibit both its pathogenicity 
and aflatoxin production without affecting the host physiology. In their zeal to find new 
anti-fungal and anti-aflatoxin agents scientists have turned towards plant and microbe 
derived compounds especially from organisms that live in aflatoxin induced 
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environments (Holmes, et al. 2008: 559-72). Vibrio gazogenes is a marine gram-negative 
bacterium notoriously known for its synthesis of antifungal pigments. Studies have 
shown that when V.gazogenes comes in contact with aflatoxin, the toxin induces 
V.gazogenes to synthesize antifungal and anti-aflatoxin compounds (Gummadidala, et al. 
2016: 814). Understanding the mechanism by which V.gazogenes decreases aflatoxin and 
inhibits pathogenicity of A.flavus will help us further understand how to develop, design 
and target A.flavus pathogen and decrease mortality rates of fungal infected patients and 
plants. Similarly, fungal bacterial interactions can be used as model systems for 
generation of new antifungals. Finally polymicrobial (bacterial and fungal) colonies pose 
a potential problem in clinical setting given their multi-drug resistance capabilities, 
understanding the molecular pathways that define the fungal bacterial interactions is an 
important step towards discovering new therapeutic targets. 
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Figure 1.1: Chemical structures of the primary 6 Aflatoxins: The lettering inside the 
chemical structure of Aflatoxin B1 represents the various rings – A and B make up the 
furofuran moiety, C is the aromatic ring, D is the lactone ring and E is either a pentone or 
lactone ring 
 
	1Gummadidala PM, Chen YP, Beauchesne KR, Miller KP, Mitra C, Banaszek N, 
Velez-Martinez M, Moeller PD, Ferry JL, Decho AW, Chanda A. Front Microbiol. 2016 
Jun 3;7:814. Reprinted here with permission of publisher 
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CHAPTER 2 
AFLATOXIN-EXPOSURE OF Vibrio gazogenes AS A NOVEL SYSTEM 
FOR THE GENERATION OF AFLATOXIN SYNTHESIS INHIBITORS1 
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2.1 ABSTRACT 
Aflatoxin is a mycotoxin and a secondary metabolite, and the most potent known 
liver carcinogen that contaminates several important crops, and represents a significant 
threat to public health and the economy. Available approaches reported thus far have 
been insufficient to eliminate this threat, and therefore provide the rational to explore 
novel methods for preventing aflatoxin accumulation in the environment. Many terrestrial 
plants and microbes that share ecological niches and encounter the aflatoxin producers 
have the ability to synthesize compounds that inhibit aflatoxin synthesis. However, 
reports of natural aflatoxin inhibitors from marine ecosystem components that do not 
share ecological niches with the aflatoxin producers are rare. Here we show that a non-
pathogenic marine bacterium, Vibrio gazogenes, when exposed to low non-toxic doses of 
aflatoxin B1, demonstrates a shift in its metabolic output and synthesizes a metabolite 
fraction that inhibits aflatoxin synthesis without affecting hyphal growth in the model 
aflatoxin producer, Aspergillus parasiticus. The molecular mass of the predominant 
metabolite in this fraction was also different from the known prodigiosins, which are the 
known antifungal secondary metabolites synthesized by this Vibrio. Gene expression 
analyses using RT-PCR demonstrate that this metabolite fraction inhibits aflatoxin 
synthesis by down-regulating the expression of early-, middle- and late- growth stage 
aflatoxin genes, the aflatoxin pathway regulator, aflR and one global regulator of 
secondary metabolism, LaeA. Our study establishes a novel system for generation of 
aflatoxin synthesis inhibitors, and emphasizes the potential of the under-explored 
Vibrio’s silent genome for generating new modulators of fungal secondary metabolism. 
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2.2 INTRODUCTION 
Aflatoxins are a group of secondary metabolites that are synthesized primarily by 
food-borne fungi such as Aspergillus parasiticus and Aspergillus flavus. These Aspergilli 
contaminate a variety of economically important crops such as corn, wheat, peanuts, tree 
nuts, dried fruits, vegetables, and medicinal plants in tropical and subtropical areas 
worldwide (Trail et al., 1995, Bennett and Klich, 2003, Chanda et al., 2009, Georgianna 
and Payne, 2009). Aflatoxin B1 is the most potent liver carcinogen known and its 
contamination in food and feed is a significant risk factor of liver cancer risk in humans 
and animals (CAST, 2003, Liu and Wu, 2010). With liver carcinomas already being the 
third leading cause of cancer-related mortality worldwide, the global increase in 
prevalence of hepatitis B virus (HBV) and immunocompromised population has 
increased the risk of aflatoxin-induced liver cancer (Liu and Wu, 2010). The elimination 
of aflatoxin accumulation in food and feed, therefore, is of primary importance for 
reducing its global burden on public health and economy. 
Common agricultural approaches used for prevention of aflatoxin contamination 
in crops include use of fungicides, biocontrol agents and fungi-resistant plants, crop 
rotation, choice of a plantation time that avoids the aflatoxin-conducive climatic 
conditions, and control of environmental factors during post-harvest (Kabak et al., 2006, 
Wu and Khlangwiset, 2010a, Wu and Khlangwiset, 2010b, Cary et al., 2011). However, 
most of these strategies are expensive, time-consuming and have demonstrated limited 
success. To complement these conventional strategies, the use of compounds and 
extracts, collected from plants and microbes that share ecological niches with the 
aflatoxin producers, are becoming increasingly popular (Holmes et al., 2008). Examples 
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of these natural compounds include a variety of naturally derived volatile compounds 
(Greene-McDowelle et al., 1999, Zeringue, 2000, Roze et al., 2004, Roze et al., 2007, 
Roze et al., 2011). Despite the significant efforts in discovering aflatoxin biocontrol 
agents, over 55 billion people worldwide still suffer from uncontrolled exposure to 
aflatoxin (Strosnider et al., 2006), resulting in an est. 25,200 to 155,000 liver cancer cases 
globally (Liu and Wu, 2010). Chronic low-level exposure to aflatoxins and other 
carcinogenic mycotoxins remains a serious health threat in the US (Kensler et al., 1992) 
and it is estimated that children in rural areas of the southern US ingest ~40 µg aflatoxin 
each day through contaminated food; a situation contributing to the significant rise in 
aflatoxin-induced liver cancer cases (Stoloff, 1976, Van Rensburg, 1977). NIH statistics 
indicate that 16,600 new cases of aflatoxin-induced liver cancer annually in the US 
(Kensler et al., 2011). Therefore, the aflatoxin monitoring programs and the destruction 
and/or decontamination of agricultural commodities, which are adopted to meet aflatoxin 
levels imposed by regulations from US and Europe for food and feed, remain an 
expensive and time-consuming process. Hence development of additional novel 
methodologies and compounds for aflatoxin elimination is essential. 
Vibrio gazogenes is an estuarine Gram-negative bacterium that is well-known for 
its ability to synthesize industrially-relevant proteins such as amylases and proteases 
(Ratcliffe et al., 1982) and bactericidal and fungicidal pigments, magnesidin A (Imamura 
et al., 1994), prodigiosins and cycloprodigiosins (Allen et al., 1983). Previous studies 
have also shown that random mutations in this bacterium with 1-methyl-3-nitro-l-
nitrosoguanidine expanded its metabolic output and activated the synthesis of additional 
bactericidal prodigiosin-related pigments, norprodigiosin and propyl prodigiosin 
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(Alihosseini et al., 2010). This prompted us to hypothesize that a portion of the 
bacterium’s metabolic potential remains silent under normal growth conditions, and can 
be activated by genetic and environmental perturbations. In this study, we conducted 
alterations of metabolism in V. gazogenes through exposures to non-toxic doses of the 
mycotoxin, aflatoxin. While aflatoxin B1 has been reported to bind to several probiotic 
bacteria (Kabak et al., 2009) and has also demonstrated the ability to alter 
bioluminescence responses in V. fischeri (Li et al., 2011), there remains a lack of 
understanding on how interaction of aflatoxin B1 or other mycotoxins affect fundamental 
bacterial cell biology. To our surprise, aflatoxin exposure to V. gazogenes diminished 
prodigiosin release into the growth medium, but additionally resulted in the production of 
a new compound that demonstrated the ability to specifically-inhibit aflatoxin synthesis 
in the model aflatoxin producer, A. parasiticus.  Here we report the findings of this study. 
We establish a novel system for generation of aflatoxin-inhibitors and provide a new 
avenue in our fundamental understanding of Vibrio cell biology. 
2.3 MATERIALS AND METHODS 
2.3.1 Strains, media, and growth conditions 
A. parasiticus, SU-1 (ATCC 56775), a wild-type aflatoxin producer. The strain 
was grown on 100 mm petri dishes containing potato dextrose agar for 2 weeks. Fresh 
spores collected from these colonies were used for all the experiments in this study that 
involved the use of SU-1. In these experiments the fungus was grown in aflatoxin-
inducing yeast-extract-sucrose (YES); a rich growth medium (containing 2% w/v yeast 
extract, 6% w/v sucrose, pH 5.8), by inoculation of 104 spores per mL of liquid medium 
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and incubated in the dark (29°C; shaking at 150 rpm). The bacterium Vibrio gazogenes 
ATCC 43942 (Farmer, Hickman-Brenner et al. 1988), that was originally isolated from 
sea water, was grown in Difco Marine Broth 2216 (BD Biosciences, Sparks, MD) at 
28°C in a shaking incubator (190 rpm). 
2.3.2 Growth measurements of A. parasiticus and V. gazogenes 
All fungal growth quantifications were performed using dry weight 
measurements. Briefly, the mycelia were filtered out of the growth media using a 
miracloth (Millipore, Billerica, MA) and dried at 75°C for 6 hrs and the final weight was 
recorded. All Vibrio growth measurements were performed using absorbance readings of 
growth media at 600 nm. 
2.3.3 Aflatoxin exposure experiments, extraction and analysis of Vibrio metabolites 
Aflatoxin B1 was commercially obtained (Sigma). Three different doses (0.1, 0.2, 
or 0.3 µg/mL) of aflatoxin B1 were added to the Vibrio growth medium at the start of the 
culture. In the control flask only the vehicle (70% Methanol) was added.  To extract the 
metabolites from V. gazogenes the cells were first harvested by centrifugation and 
extracted with 60 mL acetone. A portion of the filtrate was concentrated by evaporation 
under N2 gas. The concentrate was loaded onto a silica gel column (1.2 x 15 cm) and 
eluted with dichloromethane : methanol (80:1.5). The fractions were then purified on a 
silica gel column using chloroform and methanol (50:2). After purification the fractions 
were concentrated by evaporation under N2 gas and re-suspended in 1 mL methanol for 
spectral analysis. 
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2.3.4 ARMs exposure experiments and aflatoxin comparisons 
Comparative semi-quantitative estimations of accumulation of aflatoxin in growth 
medium was performed using thin layer chromatography (TLC) of the growth medium as 
described previously (Banerjee, Gummadidala et al. 2014) 
2.3.5 Total RNA purification and transcript analysis 
Isolation of total RNA from fungal cells exposed to aflatoxin response 
metabolites from V. gazogenes was performed using 30h old cultures. This is a time point 
that corresponds to the activation of secondary metabolism (hence the expression of 
aflatoxin genes in A. parasiticus) under the growth conditions adopted in this study 
(Roze, Arthur et al. 2007). Purification of total RNA and preparation of complementary 
DNA was performed as described previously (Chanda, Roze et al. 2009). Transcript 
levels were quantified by performing quantitative real-time PCR assays using 
SsoAdvanced universal SYBR Green supermix (BioRad Laboratories, Hercules, CA) and 
gene-specific forward and reverse primers (Table 2.1) that were designed using Primer3 
online software (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Reactions were 
performed in a CFX96 thermal cycler (Bio-Rad Laboratories, Hercules, CA). As 
described for previous gene expression studies in A. parasiticus (Roze, Arthur et al. 2007, 
Chanda, Roze et al. 2009), expression value of each gene was obtained from the 
threshold cycle values were normalized against β-tubulin (the house keeping gene) in 
each sample. All RT-PCRs were performed in triplicates for each gene per sample. Data 
analyses were performed using CFX Manager software (Bio-Rad Laboratories). 
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2.3.6 Statistical analysis 
All statistical tests were performed using GraphPad Prism Software (GraphPad, 
CA, USA). Statistical analyses to determine for statistical significance of differences 
between control versus experimental groups were determined using one-way ANOVA 
(with sample size 3). An unpaired t-test was used to determine the gene expression 
effects of ARMs on A. parasiticus compared to the untreated samples. Significance was 
set at p<0.05. 
2.4 RESULTS 
2.4.1 Aflatoxin B1 exposures do not inhibit V. gazogenes growth 
As a first step in understanding how V. gazogenes, responds to aflatoxin B1, we 
investigated the effect of three different doses of aflatoxin B1 on the growth of V. 
gazogenes. The doses, 10 ppb, 30 ppb and 50 ppb were either below, approximately equal 
to or 5-fold higher than the highest-allowed aflatoxin level (20 ppb) in food and feed 
(Mazumder and Sasmal 2001, CAST 2003 , Liu and Wu 2010). Time-course absorbance 
readings were recorded to compare the growth rates of V. gazogenes, in presence of 
aflatoxin B1, with untreated-controls. As shown in figure 2.1, none of the aflatoxin B1 
doses demonstrated any significant effect on the growth of V. gazogenes. 
2.4.2 Aflatoxin B1 exposures do not inhibit prodigiosin synthesis 
Next, we investigated the effect of aflatoxin B1 exposures on the production of 
prodigiosins by V. gazogenes. The prodigiosin fraction was obtained from cells (either 
untreated control cells or cells exposed to aflatoxin B1) using our optimized laboratory 
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protocol (see methods). Since the prodigiosins exhibit an absorbance peak at 530 nm 
(figure 2.2a), this wavelength was used to compare prodigiosin levels between 
experimental treatments and controls at three different time-points of growth (12h, 18h 
and 42h). Our results (figure 2.2b) demonstrated that although cells exposed to aflatoxin 
B1 showed a minor increase in absorbance values compared to the untreated samples, the 
difference was not statistically significant. 
2.4.3 Additional V. gazogenes metabolite fraction obtained by bacterial exposure to 
aflatoxin B1: aflatoxin response metabolites (ARMs) 
While growth and prodigiosin production by V. gazogenes was not affected in 
presence of aflatoxin B1, we observed that exposure to aflatoxin B1 resulted in a distinct 
alteration of color in the growth medium (figure 2.3a) suggesting the presence of a 
different metabolite compared to untreated cells. Based on the ‘blue-shift’ in color of the 
growth medium (bright red to orange) upon addition of aflatoxin B1, we hypothesized 
that the bacterium synthesizes an additional metabolite fraction under these conditions 
with a corresponding absorbance lower than that of the prodigiosin fraction. To test this, 
we performed UV-Vis spectral analysis on the metabolite fractions of aflatoxin B1-treated 
samples. The Vibrio metabolite fractions obtained from aflatoxin B1 treated samples 
revealed a new absorbance peak at 470 nm, in addition to the prodigiosin peak at 530 nm 
(Figure 2.3b). This suggested that aflatoxin B1 exposure affects the cellular metabolism of 
V. gazogenes resulting in a different metabolite profile, compared to the untreated 
control. Here, we denote this additional metabolite fraction in response to aflatoxin B1 
exposure as ‘aflatoxin response metabolites (ARMs)’. 
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2.4.4 ARMs do not inhibit A. parasiticus growth but inhibits aflatoxin synthesis 
Next we proceeded to investigate whether ARMs affect the aflatoxin synthesis in 
the model aflatoxin B1 producer, A. parasiticus. The activation of ARM production by 
Vibrio occurred upon addition of aflatoxin B1 to their growth medium. Therefore, we 
envisioned this alteration of metabolite profiles as a defensive response from Vibrio cells. 
We hypothesized that ARMs will have a specific inhibitory effect on aflatoxin synthesis 
in the producer cells. To test this we studied the growth and aflatoxin production by A. 
parasiticus in presence of two different doses of the ARMs metabolite fraction (1 µg and 
2 µg per mL of growth medium); the doses were chosen arbitrarily. To compare the 
levels of aflatoxin biosynthesis in A. parasiticus exposed to ARMs exposed with the 
untreated cells, we adopted a semi-quantitative approach in which we compared the 
intensities of aflatoxin B1 and aflatoxin B2 bands on the thin-layer chromatography (TLC) 
plates (see methods). As predicted, our TLC results generated from 40h cultures of A. 
parasiticus, demonstrated that ARMs applied at the concentration of 2 µg per mL of 
growth medium inhibited both aflatoxin B1 and aflatoxin B2 by approximately 2-fold 
(figure 2.4a). Since the drop in aflatoxin synthesis could also have resulted from the 
inhibition of A. parasiticus growth, we next compared the dry-weights of the A. 
parasiticus mycelia exposed to 1 and 2 µg per mL of ARMs extract with the untreated 
control mycelia. As shown in figure 2.4b, addition of ARMs to the growth medium did 
not result any significant change in A. parasiticus dry weight, suggesting that inhibition 
of aflatoxin synthesis in A. parasiticus by ARMs was a direct effect and not a growth 
dependent effect. 
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2.4.5 ARMs metabolite fraction displays a different HPLC trace compared to prodigiosin 
fraction 
Our UV-Vis spectral analysis suggested that ARMs were synthesized by V. 
gazogenes upon exposure to aflatoxin. We then proceeded to confirm that this fraction 
(peak absorbance at 470 nm) was composed of metabolites of molecular masses that are 
different from the Vibrio’s prodigiosin fraction (peak absorbance at 530 nm). As shown 
in figure 2.5, HPLC traces showed that the prodigiosin fraction predominantly 
demonstrated the expected molecular weight of 324 D, corresponding to the known 
prodigiosin. The HPLC trace of ARMs on the contrary was clearly different, with a 
predominantly displayed molecular mass 232 D, which demonstrate that the metabolite 
fraction of ARMs was chemically different from the Vibrio’s prodigiosin fraction. These 
results suggest that the differential metabolite profile in response to aflatoxin exposure 
can occur either due to synthesis of new metabolites by V. gazogenes or due to 
breakdown of prodigiosins resulting in novel smaller molecules with aflatoxin synthesis 
inhibitory activity. 
2.4.6 ARMs inhibit A. parasiticus aflatoxin biosynthesis at the level of transcript 
accumulation 
The fungal growth and aflatoxin results then prompted us to investigate whether 
aflatoxin biosynthesis was inhibited at the level of transcript accumulation of aflatoxin 
genes. To conduct this analysis we performed a quantitative comparison of transcript 
accumulation of two genes nor-1, and ver-1 that encode two enzymes, Nor-1, Vbs and 
Ver-1 respectively involved in the aflatoxin biosynthetic pathway (Chanda, Roze et al. 
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2009). Activation of these genes in A. parasiticus occurs at 24h, and transcripts of all 
aflatoxin enzymes accumulate by 30h, when the fungus is grown in YES growth medium 
(Roze, Arthur et al. 2007). Hence we chose to examine the effects of ARMs extract on A. 
parasiticus at three different time-points, 24h, 30h and 40h, a time-point when aflatoxin 
is synthesized by the fungus at peak levels (Roze, Arthur et al. 2007). In addition to these 
genes, we also compared the transcript accumulation of the aflatoxin pathway regulator, 
aflR, at the same time points. As shown in figure 2.6, nor-1, ver-1 as well as the aflR 
genes transcript levels demonstrated ≥5 fold reduction in presence of ARMs extract 
compared to the vehicle control by 30h. Hence, our results suggest that ARMs extract 
reduces aflatoxin synthesis at the level of transcript accumulation. 
2.4.7 ARMs inhibit transcript accumulation of the secondary metabolism global 
regulator, laeA but not veA 
Since the regulatory network of the aflatoxin biosynthesis pathway is integral to 
the global network of secondary metabolism in A. parasiticus as described in a recent 
review by Brakhage (Roze, Arthur et al. 2007), we also proceeded to investigate whether, 
ARMs target the global regulation of secondary metabolism. One key global regulatory 
complex of fungal secondary metabolism is the VeA complex (Bayram, Krappmann et al. 
2008). Central to this complex is the cross-talk between the two global regulators, LaeA, 
a methyltransferase that is key to the epigenetic regulation of aflatoxin biosynthetic 
pathway (Bok and Keller 2004), and VeA, a light responsive regulator that migrates from 
cytoplasm to the nucleus in absence of light to form the VeA complex with LaeA and 
other components in the complex (Bayram, Krappmann et al. 2008). In this study we 
investigated whether ARMs affect transcript accumulation of either laeA or veA genes. 
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To our surprise we found that, while no significant changes occurred in veA transcripts, 
the laeA transcript accumulation was reduced by ~2 fold by 30h and ~4 fold by 40h 
(figure 2.7), suggesting that ARMs inhibit aflatoxin biosynthesis at least in part, through 
inhibition of LaeA. 
2.5 DISCUSSION 
Here we demonstrate the feasibility of a novel system for generation of aflatoxin 
biosynthesis inhibitors, a concept that is analogous to the generation of antibodies upon 
antigen exposure. Our data reveal that the estuarine bacterium V. gazogenes, upon 
aflatoxin exposure, produces a metabolite profile that is chemically different from 
untreated-cells. Upon isolation of the ARMs and applying them on the aflatoxin producer 
cells, we found that the metabolites inhibit aflatoxin biosynthesis at the levels of 
transcript accumulation. Based on our current study we propose two possible 
explanations underlying this inhibition (illustrated in the schematic in figure 2.7). One 
possible mechanism of inhibition is through the regulation of the laeA gene activation. 
The laeA transcripts dropped by 2-4 fold during 30h to 40h time points suggesting that 
ARMs inhibit the formation of the Velvet complex, a protein complex comprising LaeA 
protein that regulate fungal secondary metabolism (Bayram, Krappmann et al. 2008). 
Alternatively, it is also possible that in addition to laeA mediated inhibition ARMs inhibit 
the activation of aflatoxin genes directly. Fungal growth was not inhibited during the 
ARMs-mediated inhibition of aflatoxin biosynthesis, suggesting that the metabolites 
target secondary metabolism specifically.  Future studies will identify the molecule(s) 
within ARMs that results in the aflatoxin inhibition. From our current preliminary 
studies, we postulate that two or more compounds generated in response to aflatoxin 
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exposure act either complementarily or synergistically to inhibit aflatoxin synthesis 
inhibition. These collaborative effects will be determined in those functional 
characterization studies with the purified compounds. 
It is important to emphasize that specific aflatoxin inhibitory natural products that 
have been characterized to-date were reported primarily from terrestrial organisms whose 
ecological domains likely overlap with those of the aflatoxin producers. Examples 
include natural products and volatiles from plants (Cleveland, Carter-Wientjes et al. 
2009, Roze, Koptina et al. 2011, Chitarrini, Nobili et al. 2014), fungi (Ono, Sakuda et al. 
1997, Yoshinari, Noda et al. 2010, Hua, Beck et al. 2014) and bacteria (Jermnak, 
Chinaphuti et al. 2013, Wang, Yan et al. 2013, Kong, Chi et al. 2014). Our study provides 
the first evidence, to the best of our knowledge, of an organism that demonstrates the 
ability of synthesizing aflatoxin inhibitors, while not sharing ecological niches with 
aflatoxin producers at all. Also this is the first report, to the best of our knowledge, of a 
Vibrio-producing metabolite(s) that specifically inhibit aflatoxin biosynthesis without 
affecting fungal growth. It is possible that mycotoxin triggered synthesis of mycotoxin 
inhibitors is a phenomenon that is conserved in the Vibrio species. Alternatively, it is also 
possible that Vibrio gazogenes is a chemically-gifted organism that has genetically 
evolved with the rising mycotoxin levels in the environment with global changes in 
climate (Kolpin, Schenzel et al. 2014, Rangel, Alder-Rangel et al. 2015). 
The effect of ARMs mediated down-regulation of laeA gene, but not veA gene 
suggests that the metabolites target cellular signaling receptors that specifically regulate 
laeA gene expression. Since LaeA is a global regulator of secondary metabolism and 
influences several mycotoxin biosynthetic pathways (Keller, Turner et al. 2005), we 
 
 
21 
anticipate that aflatoxin inhibitor within ARMs will inhibit other mycotoxins as well. 
Hence, for our follow-up studies we will categorize these as secondary metabolism 
specific inhibitors instead denoting these as specific inhibitors against aflatoxin 
biosynthesis. 
Current investigations in our laboratory reveal that other fungal secondary 
metabolites trigger synthesis of metabolite fractions in V. gazogenes that demonstrate 
different HPLC traces compared to either prodigiosins or ARMs fractions. These results 
implicate the need to examine the regulation of Vibrio genes under different 
environmental signals. It appears from our studies that many areas of the Vibrio genome 
remain silent under standard laboratory growth conditions and can be activated as needed 
to generate metabolites that are relevant to the public health. Our future studies will shed 
light on these silent areas of the V. gazogenes genome that encode the biosynthesis of the 
secondary metabolism modulatory metabolites; the knowledge will enable us to clone 
these areas on plasmids and engineer them as needed with the goal of purifying these 
compounds in large quantities. 
 
 
22 
Table 2.1: List of PCR primers used for this study 
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Figure 2.1: Effect of Aflatoxin B1 exposure on Vibrio gazogenes growth: Growth 
comparisons were performed using comparisons of 600 nm absorbance values between 
untreated V. gazogenes cultures and cultures were supplemented with 10, 30, and 50 ppb 
of aflatoxin B1. Statistical significance of two-tailed p-values were determined using an 
unpaired t-test with sample size of 3 and significance set as p < 0.05. 
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Figure 2.2: Effect of aflatoxin B1 exposure on prodigiosin production: (A) UV-Vis 
spectral profile of a prodigiosin-rich metabolite fraction demonstrating peak absorbance 
at 530 nm. (B) Comparison of absorbance values at 530 nm, of methanol extracts from 
untreated V. gazogenes cultures and cultures were supplemented with 10, 30, and 50 ppb 
of aflatoxin B1. Statistical significance of two-tailed p-values were determined using an 
unpaired t-test, with n=3, and p < 0.05 as significance level. 
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Figure 2.3: Aflatoxin-response metabolites (ARMs) produced by the bacterium V. 
gazogenes during exposure to aflatoxin B1 (AFB1). (A) Representative flasks 
demonstrating the differences in appearance of untreated V. gazogenes cultures and the 
aflatoxin B1 supplemented cultures. (B) Comparison of UV-Vis profiles of the methanol 
extracts from untreated and supplemented V. gazogenes cultures. 
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Figure 2.4: Effect of ARMs on aflatoxin biosynthesis and fungal growth. (A) Effect on 
aflatoxin accumulation in the growth media: Left panel, a representative TLC plate 
providing a qualitative comparison of aflatoxin accumulation in the untreated culture and 
cultures that were supplemented with 1 and 2 µg/mL ARMs extract and the vehicle 
(DMSO). Right panel, semi-quantitative comparative comparisons of band intensities of 
aflatoxin B1 and aflatoxin B2. a, significant difference in band intensity compared to the 
vehicle control. (B) Effect on growth: Comparison of dry-weight measurements. Bars 
represent measurements relative to the dry-weight of untreated cells. Statistical 
significance of two-tailed p-values were determined using an unpaired t-test, with sample 
size of n = 3 and p < 0.05 set as level of significance.  
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Figure 2.5: Comparison of HPLC traces of ARMs extract and the prodigiosin fraction of 
V. gazogenes. 
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Figure 2.6: Effects of ARMs on Aspergillus parasiticus gene expression. (A) Comparison 
of transcript accumulation of aflatoxin-synthesis regulatory genes in A. parasiticus. 
mRNA levels for each gene were observed at 24 h (aflatoxin synthesis start point), 30 and 
40 h time points (aflatoxin synthesis is activated and reaches peak levels by 40 h). Black 
bars, cells grown in presence of ARMs (2 µg/mL), Gray Bars, DMSO (vehicle) control. 
(B) Comparison of transcript accumulation of two global regulators of secondary 
metabolism, veA and laeA at the same time-points. Statistical significance of difference in 
transcript accumulation between control and ARMs-treated cells were determined using 
an unpaired t-test with sample size of 3 and two tailed p < 0.05 set as level of 
significance. a, p < 0.05. 
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Figure 2.7: Schematic representation of the inhibitory effect of ARMs on aflatoxin 
biosynthesis: Current study demonstrates that ARMs inhibit aflatoxin biosynthesis in A. 
parasiticus at the level of gene expression. We hypothesize that the inhibition of aflatoxin 
genes as exemplified by the decreased nor-1, ver-1, and aflR transcripts in presence of 
ARMs can be the effect of one or both of the following: (1) inhibition of laeA expression, 
which in turn can have inhibitory impact on the activation of the aflatoxin genes, or (2) a 
dual inhibition caused by direct inhibition on aflatoxin gene cluster activation along with 
a laeA mediated inhibition. Red dotted arrows, regulatory roles established in previous 
studies, red solid lines, inhibitory effect, gray curved arrows, gene activation, gray solid 
line, schematic of the aflatoxin gene cluster showing relative positions of nor-1, ver-1, 
and aflR in the cluster, brown solid line, laeA gene. 
1Gummadidala PM, Holder ME, O'Brien JL, Ajami NJ, Petrosino JF, Mitra C, Chen YP, 
Decho AW, Chanda A. Genome Announc. 2017 Jul 27;5(30). Reprinted with permission 
from publisher. 
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CHAPTER 3 
COMPLETE GENOME SEQUENCE OF Vibrio gazogenes ATCC 439421 
	 31 
3.1 ABSTRACT 
Vibrio gazogenes ATCC 43942 has the potential to synthesize a plethora of 
metabolites in response to environmental triggers, which are of clinical and agricultural 
significance. The complete genomic sequence of Vibrio gazogenes ATCC 43942 is 
reported herein contributing to the knowledgebase of strains in the Vibrio genus. 
3.2 INTRODUCTION 
Vibrio gazogenes is an estuarine Gram-negative bacterium that is known for its 
ability to synthesize industrially relevant proteins such as amylases and proteases 
(Ratcliffe, Sanders et al. 1982), and bactericidal and fungicidal pigments, magnesidin A 
(Imamura, Adachi et al. 1994), prodigiosins, and cycloprodigiosins (Allen, Reichelt et al. 
1983). 
V. gazogenes ATCC 43942 was recently studied by our laboratory for its response 
to aflatoxin, a hepatocarcinogen and a mycotoxin that is produced from a group of 
filamentous fungi under the genus Aspergilli. The bacterium demonstrated the ability to 
generate a group of metabolites (named aflatoxin response metabolites, denoted as 
ARMs) that were able to inhibit aflatoxin synthesis in the aflatoxin producer, Aspergillus 
parasiticus (Gummadidala, Chen et al. 2016). Also, in our ongoing (unpublished) studies, 
we have consistently observed the ability of this Vibrio strain to degrade mycotoxins and 
generate a unique set of antibiotics that are active against multiple antibiotic resistant 
bacterial strains. These observations prompted us to categorize this bacterium as 
clinically and agriculturally significant, and have provided the rationale for sequencing its 
genome. 
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Genomic DNA extraction (10 – 20 µg) was performed using PureLink genomic 
DNA minikit (Invitrogen). The extracted DNA was quantified using Nanodrop 1000 
(Thermo Scientific) and quality of the DNA was assessed by running a 1% agarose gel 
with the DNA gel stain SYBR safe (Life Technologies) and visualized in a ChemiDoc 
MP system (Bio-Rad). DNA sequencing was performed on the Pacific Biosciences RS II 
platform. One SMRT cell, yielding 73,434 post-filtered polymerase reads and having an 
N50 read length of 26,245 bases and a mean read length of 16,358 bases, was used for 
assembly in Pacific Biosciences’s SMRT Analysis v2.3.0 package using the 
RS_HGAP_Assembly.2 protocol5. Quiver was subsequently used to polish the assembly. 
The finished genomic sequences were annotated with NCBI’s Prokaryotc Genome 
Annotation Pipeline. A high-quality finished version of the V. gazogenes genome is 
reported here as two circular chromosomes and one circular plasmid with a mean 
coverage of 185x with features as follows: 
(1) Chromosome 1 (denoted as Chr_1): size 3,471,064 bp; GC% 45.5; proteins 
2,988; rRNA 25; tRNA 87; ncRNA 4; Genes 3153; Pseudogenes 49, 
(2) Chromosome 2 (denoted as Chr_2): Chr_2; size 1,303,572 bp; GC% 44.9; 
proteins 1,102; tRNA 4; Genes 1,138; Pseudogenes 32, and 
(3) Plasmid (denoted as P_1): size 11,916 bp; GC% 45.2; proteins 22; Genes 23; 
Pseudogene 1. 
The utility of prodigiosins that are synthesized by V. gazogenes ATCC43942 
coupled with its ability to produce unique antibiotics and mycotoxin inhibitors under 
custom designed environmental settings make this strain ‘chemically gifted’. In this 
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context, its finished genomic sequence provides a necessary point of comparison with 
other V. gazogenes strains and bacterial species within the Vibrio genus for elucidation of 
the molecular factors that govern its unique metabolic profile. 
3.3 Nucleotide sequence accession numbers(s) 
The sequence of V. gazogenes ATCC 43942 has been deposited in NCBI 
GenBank under the accession no(s) that are as follows: CP018835, CP018836 and 
CP018837. 
	1Kenne GJ*, Gummadidala PM*, Omebeyinje MH, Mondal AM, Bett DK, McFadden S, 
Bromfield S, Banaszek N, Velez-Martinez M, Mitra C, Mikell I, Chatterjee S, Wee J, 
Chanda A.Toxins (Basel). 2018 Jan 29;10(2). *Co-first authors. Reprinted with 
permission from publisher. 
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CHAPTER 4 
ACTIVATION OF AFLATOXIN BIOSYNTHESIS ALLEVIATED 
TOTAL ROS IN Aspergillus parasiticus1 
	 35 
4.1 ABSTRACT 
An aspect of mycotoxin biosynthesis that remains unclear is its relationship with 
the cellular management of reactive oxygen species (ROS). Here we conduct a 
comparative study of the total ROS production in the wild-type strain (SU-1) of the plant 
pathogen and aflatoxin producer, Aspergillus parasiticus, and its mutant strain, AFS10, in 
which the aflatoxin biosynthesis pathway is blocked by disruption of its pathway 
regulator, aflR. We show that SU-1 demonstrates a significantly faster decrease in total 
ROS than AFS10 between 24 h to 48 h, a time window within which aflatoxin synthesis 
is activated and reaches peak levels in SU-1. The impact of aflatoxin synthesis in 
alleviation of ROS correlated well with the transcriptional activation of five superoxide 
dismutases (SOD), a group of enzymes that protect cells from elevated levels of a class of 
ROS, the superoxide radicals (O2−). Finally, we show that aflatoxin supplementation to 
AFS10 growth medium results in a significant reduction of total ROS only in 24 h 
cultures, without resulting in significant changes in SOD gene expression. Our findings 
show that the activation of aflatoxin biosynthesis in A. parasiticus alleviates ROS 
generation, which in turn, can be both aflR dependent and aflatoxin dependent. 
4.2 INTRODUCTION 
Filamentous fungi synthesize and release a diverse array of secondary metabolites 
into their environment, many of which have profound impacts on agriculture, industry, 
environmental sustainability, and human health (Keller et al., 2005). Many compounds 
are used as medicines, including statins, penicillin, and other antibiotics. Many others, 
like aflatoxins and fumonisins, can be life threatening to humans and animals. Aflatoxin 
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B1 (AFB1), a highly carcinogenic secondary metabolite synthesized by a group of 
Aspergilli, is a life-threatening toxin causing significant morbidity and mortality 
worldwide, as well as billions of dollars in annual economic losses (Magnussen et al., 
2013). Due to the significant human and agricultural impacts of aflatoxin (AF), its 
biosynthetic pathway is one of the most characterized and widely studied models for 
understanding fungal secondary metabolism (Roze et al., 2011). 
The aflatoxin biosynthesis process is activated by several environmental cues and 
orchestrated by a complex regulatory network of more than 25 genes and 17 enzymatic 
steps (Brakhage et al., 2013; Yin et al., 2011; Yu et al., 2004; Chanda et al., 2009). The 
operation of this network is governed by the interactions of a set of global transcription 
factors, including LaeA and VeA (Brakhage et al., 2013; Kale et al., 2008; Bayram et al., 
2008; Calvo et al., 2004; Calvo et al., 2008; Duran et al., 2007). Upon receiving signals 
from cell surface receptors, these global transcription factors communicate with pathway-
specific transcription factors [examples include AflR (Cary et al., 2006) and GliZ (Scharf 
et al., 2012; Bok et al., 2006)] to activate specific aflatoxin biosynthesis genes. Many of 
the enzymes synthesized by this pathway then localize to specific vesicles known as 
toxisomes (Chanda et al., 2009; Chanda et al., 2010; Roze et al., 2011; Lim et al., 2014; 
Menke et al., 2013), which provide a platform for the completion of biosynthesis, 
sequestration, and export of aflatoxin to the environment (Chanda et al., 2009; Chanda et 
al., 2010; Roze et al., 2011; Lim et al., 2014; Menke et al., 2013).  
To manipulate secondary metabolism in fungi for the benefit of public and 
environmental health, it is essential to understand the motivation for a fungal cell to 
preserve such an energy-consuming metabolic process with enormously complex 
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molecular and cellular organization throughout the course of evolution. One of the most 
commonly hypothesized functions of fungal secondary metabolites is defense against 
other organisms in the same ecological niche. Antibacterial properties of secondary 
metabolites like penicillin and other beta-lactam antibiotics are well established in 
literature (Van Krimpen et al., 1987). Beyond antibacterial properties, reports from 
Rohlfs et al. (Rohlfs et al., 2007) suggest that aflatoxin and sterigmatocystin protect 
fungal cells from pests and insects. These studies all suggest that secondary metabolism 
provides fungi with a survival mechanism in nature. 
Several recent studies suggest that secondary metabolism is integrated with 
primary metabolism and its associated cellular mechanisms (Roze et al., 2011; Chanda et 
al., 2009; Linz et al., 2012; Roze et al., 2010), which implies that secondary metabolism 
may have a regulatory impact on other fungal cellular processes as well. One cellular 
process that appears to be associated with secondary metabolism in fungi is oxidative 
stress response. Recently, several basic leucine zipper (bZIP) transcription factors in 
filamentous fungi have been reported in the literature that not only regulate antioxidant 
genes participating in oxidative stress response, but are also associated with the 
regulation of secondary metabolism (Roze et al., 2011; Baidya et al., 2014; Hong et al., 
2013; Hong et al., 2013; Montibus et al., 2013; Reverberi et al., 2012; Montibus et al., 
2015; Yin et al., 2013). These reports are in line with previous reports (Jayashree et al., 
2000; Narasaiah et al., 2006; Reverberi et al., 2006; Reverberi et al., 2008) suggesting 
that oxidative stress induces aflatoxin synthesis in Aspergillus parasiticus. 
While these lines of evidence collectively demonstrate that the two cellular 
processes (aflatoxin biosynthesis and intracellular oxidative stress management) 
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communicate at different regulatory nodes and are co-regulated, the effect of aflatoxin on 
oxidative stress remains unclear. In this study we address this knowledge gap through a 
comparative study of total reactive oxygen species (ROS) output between the wild-type 
A. parasiticus and its mutant, AFS10, in which the aflatoxin pathway regulator gene, 
aflR, is disrupted (Cary et al., 2002; Ehrlich et al., 1999). In addition to measuring ROS, 
we also conducted a comparative assessment of superoxide dismutase (SOD) gene 
expression. SODs are conserved in eukaryotes and are synthesized in response to 
intracellular (O2−) radicals (a type of ROS) generated as a byproduct of primary cellular 
functions (Fridovich 1975). To differentiate the aflatoxin-dependent effect on ROS 
generation from the possible genetic effects (of aflR disruption) we also conducted 
aflatoxin supplementation studies on AFS10. The results of this work provide direct 
evidence in support of the regulatory role of aflatoxin synthesis on total ROS output and 
explain the rationale for the co-regulation of oxidative stress with aflatoxin synthesis. 
4.3 MATERIALS AND METHODS 
4.3.1 Strains, media and growth conditions 
Aspergillus parasiticus wild type strain SU-1 (ATCC56775) and the aflR 
disrupted mutant, AFS10 (Ehrlich et al., 1999; Roze et al., 2007), were used for this 
study. Yeast extract sucrose (YES) (2% yeast extract, 6% sucrose; pH 5.8) was used as 
the liquid growth medium for the entire study for both strains. Fungal cells were grown 
for 24 h and 48 h by inoculating 107 spores per 100 mL of growth medium and 
incubating the cells at 29°C in a dark orbital shaker at 150 rpm. 
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4.3.2 Quantification of ROS 
Comparison of ROS concentrations between SU-1 and AFS10 was conducted 
spectrophotometrically using 2′,7′-dichlorofluorescein diacetate (DCFH-DA) based on a 
previously described protocol (Chang et al., 2011). Equal weight (0.5 g) of mycelia from 
a 24 and 48 h culture was placed into 1 mL of freshly made 1 µM DCFH-DA in 
phosphate buffered saline (PBS). After 4 h of incubation in the dark at room temperature 
(25°C), the fluorescent yield of the DCFH-DA oxidation product, dichlorofluorescin 
(DCF), was measured using a Victor™ X3 2030 Multilabel Reader (PerkinElmer, 
Waltham, MA, USA) with an excitation/emission wavelength of 490/525 nm. 
4.3.3 Identification of Superoxide Dismutase genes 
Since functional characterization of the SOD genes in A. parasiticus has not yet 
been completed, a bioinformatics analysis was performed to identify SOD gene 
sequences to allow for a comparative expression analyses to address our hypothesis. The 
SOD genes analyzed in this study were identified by searching for “superoxide 
dismutase” in the accessible genome database (Yu et al., 2008) of A. flavus, a close 
relative of A. parasiticus that exhibits ~98–100% amino-acid sequence identity with A. 
parasiticus proteins that have been sequenced (Roze et al., 2011). The search rendered 
five annotated amino-acid sequences which were then queried in the PROSITE database 
(Sigrist et al., 2013) against the 390 available SOD genes to investigate whether they 
contained (a) the conserved functional domains typical of SODs, or (b) motifs with a high 
probability of occurrence that are commonly present in the SOD genes. Details of these 
sequences and queries can be found in table 4.1. 
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4.3.4 RNA extraction, purification and cDNA synthesis 
Total RNA was extracted from cells harvested using a TRIzol-based (TRIzol 
Reagent; Invitrogen, Carlsbad, CA, USA) method previously described (Chanda et al., 
2009). Within 24 h of extraction, RNA cleanup was performed using a Qiagen RNEasy 
Cleanup Kit (Qiagen, Valencia, CA, USA), and samples were stored at −80°C. Total 
RNA was then reverse transcribed to cDNA using iScript™ cDNA Synthesis Kit 
(BioRad Laboratories, Hercules, CA, USA). All samples were checked for concentration 
and purity after each step using a NanoDrop 2000 Spectrophotometer (Thermo-Fisher 
Scientific, Waltham, MA, USA). All cDNA samples were stored at −20°C until 
subsequent PCR quantification. 
4.3.5 Quantitative PCR Assays 
Expression of SOD genes was examined by quantitative PCR assays (qPCR) 
using SsoAdvanced Universal SYBR Green Supermix (BioRad Laboratories, Hercules, 
CA) and gene specific forward and reverse primers (table 4.2) designed using Primer3 
online software (Ye et al., 2012). Reactions were performed per BioRad SYBR Green 
protocol guidelines and quantified using a CFX96 thermal cycler (Bio-Rad Laboratories, 
Hercules, CA, USA). 
The 18s ribosomal DNA was used as a reference in the gene expression 
experiments, with β-tubulin used as a positive control rather than a reference gene. This 
use of β-tubulin in this manner provided proof of consistent quantification across all 
experiments and revealed an expected range of variation within the protocol. Expression 
of each SOD gene was obtained from the threshold cycle values normalized against 18s 
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rDNA in each sample. All RT-PCRs were performed in triplicate for each gene per 
sample. For quantitative comparison of gene expression, the expression values for each 
target gene at the early stationary phase (48 h) were expressed as the fold change relative 
to the 24 h time point to reflect changes associated with the initiation of aflatoxin 
biosynthesis, which begins at 30 h (Roze et al., 2015). All data analysis was performed 
using CFX Manager software (Version 3.1, Bio-Rad Laboratories, Hercules, CA, USA, 
2012). 
4.3.6 Aflatoxin supplementation experiments 
For aflatoxin supplementation studies, 0.5 g of AFS10 mycelia were collected 
from YES media at 24 and 48 h and each placed in 12-well trays containing 1 mL of their 
culture media. Total aflatoxin (in 70% methanol solution) isolated from an SU-1 culture 
using our standard chloroform-methanol isolation procedure (Gummadidala et al., 2017) 
was added to each sample well at a final concentration of 50 ppm. The control mycelia 
were supplemented with an equal volume of 70% methanol solution. After a 4 h 
incubation, mycelia were transferred to 1 mL of 1 µM DCFH-DA in PBS substrate for an 
additional 1 hour incubation in the dark before being measured (in triplicate) for DCF 
fluorescence. Aflatoxin uptake into the mycelia during the incubation period was 
quantified by measuring total percent removal of aflatoxin from the medium every hour 
until 4 h and by measuring the total accumulation of aflatoxin in the mycelium in parallel, 
after 4 h. Percent removal of aflatoxin from the medium was calculated as follows: 
Percent removal = ((Initial total aflatoxin in the supplementation medium − total 
aflatoxin in the medium at a time point)/Initial total aflatoxin in the supplementation 
medium) × 100. Aflatoxin was quantified in the medium as described below. Aflatoxin 
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accumulation in the mycelium was measured after washing three times with PBS buffer 
followed by extracting aflatoxin from the mycelium using a chloroform: methanol 
procedure as described previously (Roze et al., 2007). Aflatoxin in the extract was then 
measured using an enzyme-linked immunosorbent assay (ELISA). Dead cells of AFS10 
obtained upon autoclaving at 121°C for 15 min were used in the uptake experiments as 
controls for free diffusion systems. Loss of viability in these cells was confirmed prior to 
experimentation by confirming their inability to grow in fresh growth medium. 
4.3.7 Aflatoxin quantification 
Qualitative comparisons of aflatoxin accumulation in the growth media were 
performed using thin-layer chromatography (TLC) as described previously (Hong et al., 
2008). Quantification of aflatoxin for the aflatoxin uptake experiments was performed 
using a Veratox for Aflatoxin ELISA kit (Neogen Food Safety, Lansing, MI, USA) and 
measured on a Stat Fax 4700 Microstrip Reader (Awareness Technologies, Palm City, 
FL, USA). 
4.3.8 Satistical analysis 
Statistical analyses for this study were conducted using the GraphPad Prism 
Software (GraphPad, CA, USA). The statistical significance of two-tailed p-values were 
determined using an unpaired t-test, using n = 3 and p < 0.05. For the gene expression 
studies, a two-fold increase or decrease in transcript level was our cutoff for comparing 
expressions between two genes. 
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4.4 RESULTS 
4.4.1 SU-1 demonstrates a significantly larger decrease in total ROS compared to AFS10 
between 24h and 48h 
Aflatoxin biosynthesis is activated in SU-1 at 24 h under our culture conditions 
and reaches peak levels by the start of the stationary phase at 48 h (Skory et al., 1993; 
Chanda et al., 2009). Under these conditions aflatoxin biosynthesis is not activated in 
AFS10. As shown in figure 4.1a, during the 24h – 48h time window, aflatoxin 
accumulation in the growth medium was observed and aflatoxin genes were activated in 
SU-1 but not in AFS10. The genes nor-1 and ver-1 were chosen as representative 
aflatoxin genes that demonstrated drastic increases in expression similar to previously 
reported semi-quantitative analysis of transcript and protein analysis (Roze et al., 2007). 
Quantitative comparison of total ROS (Dichlorodihydrofluorescein [DCF] fluorescence 
measurements shown in Figure 4.1b) shows that at 24 h both strains demonstrate similar 
levels of total ROS, but by 48 h the total ROS decreased at a significantly higher rate in 
SU-1 than in AFS10. This demonstrated an association between the activation of 
aflatoxin biosynthesis and a decrease in total ROS, which may be attributable to either 
the presence of aflatoxin or the regulatory role of aflR. 
4.4.2 Higher total ROS in AFS10 compared to SU-1 at 48h associates with significant 
differences in SOD gene expression 
4.4.2.1 Bioinformatics analysis of SOD genes 
Since SOD genes are synthesized in eukaryotes in response to intracellular O2− 
radicals (a type of ROS) generated as a byproduct of primary cellular functions 
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(Fridovich 1975), we investigated whether higher ROS at 48 h in AFS10 is correlated 
with the transcriptional activation of SOD genes. As a first step to do so we initiated a 
search for SOD genes within the available genome database of a closely related species, 
A. flavus (Yu et al., 2008) and identified five amino acid sequences (table 4.1). Out of 
these five sequences, two different sequences of copper–zinc SOD genes are annotated in 
the database as CuZnsod1 and cytosolic CuZnsod, two sequences of iron SOD are 
annotated as Fesod and FesodA, and one manganese SOD is annotated as Mnsod. These 
five sequences were queried against the PROSITE database (Sigrist et al., 2013) to verify 
whether they contained any of the conserved functional domains or patterns that are 
present in the well-characterized SODs within the database. 
As shown in table 4.2A, two of these sequences contained superoxide dismutase 
(SOD) signatures. CuZnsod1 had two typical CuZn SOD signatures. The conserved 
sequence (AFHVHQfGDnT) matched with the consensus pattern, [GA]-[IMFAT]-H-
[LIVF]-H-[S]-x-[GP]-[SDG]-x-[STAGDE], for signature 1, where 2 H’s are copper 
ligands. Similarly, conserved sequence (GNAGaRpACgvI) matched with the consensus 
pattern, G-[GNHD]-[SGA]-[GR]-x-R-x-[SGAWRV]-C-x(2)-[IV], for signature 2, where 
C is involved in a disulfide bond. Mnsod contained the conserved sequence, 
DmWEHAYY, corresponding to manganese and iron SOD signature. This signature 
matched with the consensus pattern, D-x-[WF]-E-H-[STA]-[FY](2), where D and H are 
manganese/iron ligands. 
The PROSITE database was then used to investigate whether the three other 
sequences that did not contain typical SOD motifs contained regions that have high 
probability of occurrence (frequent patterns) in SODs. The remaining three amino acid 
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sequences displayed the four patterns (an N-myristoylation site, a Casein kinase II 
phosphorylation site, and N-glycosylation site, and a Protein kinase C phosphorylation 
site) that are the most frequently present within the 390 SOD genes available in 
PROSITE database, suggesting strongly that these are SOD sequences (table 4.2B). 
4.4.2.2 Expression profiles of SOD genes 
The gene expression of all five SODs was examined in both SU-1 and AFS10 at 
24 h and 48 h post-inoculation in yeast extract sucrose (YES). Quantitative comparison of 
the transcript levels between 24 h and 48 h, with levels normalized to 24 h (raw 
expression data relative to 18s rRNA shown in Figure S1) are shown in figure 4.2 and 
the list of primers used are mentioned shown under table 4.3. The data suggest that SOD 
expression profile in this fungus is growth phase dependent. Hence, while the expressions 
of Fesod and CuZnsod1 are higher in 24 h cultures (corresponding to the exponential 
growth phase) the Mnsod expression is significantly higher in the 48 h cultures 
(corresponding to the stationary growth phase). As seen in figure 4.2, AFS10 displayed a 
significantly larger increase in Mnsod expression from 24 h to 48 h (~70-fold increase in 
AFS10 versus a ~40 fold increase in SU-1). Additionally, CuZnsod expression that 
remained constant in SU-1 showed a significant increase from 24 to 48 h in AFS10. No 
significant difference was observed between SU-1 and AFS10 for genes Fesod and 
CuZnsod1. Our results, therefore, demonstrate an association between higher ROS levels 
in AFS10 (compared to SU-1) and absence of aflatoxin biosynthesis during the 24 h–48 h 
time window in AFS10 with the significantly larger increases (compared to SU-1) in 
Mnsod and CuZnsod transcripts from 24 h to 48 h. 
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4.4.3 Aflatoxin supplementation to AFS10 growth medium changes total ROS output 
without changing the SOD transcript levels 
The significantly larger decrease in total ROS in SU-1 compared to AFS10 could 
either be aflatoxin dependent, aflR dependent, or both. To examine if total ROS 
production is in-part aflatoxin dependent, we investigated whether aflatoxin 
supplementation to AFS10 impacts the total ROS levels. The results from this experiment 
are shown in figure 4.3. A 4 h supplementation of 24 h mycelia with total aflatoxin 
isolated from an SU-1 growth medium resulted in a significant decrease of total ROS 
(figure 4.3a). In contrast, the 4 h aflatoxin supplementation to 48 h AFS10 mycelia 
significantly increased the total ROS. To understand this differential effect of aflatoxin 
supplementation on the 24 h and 48 h AFS10 cultures, we conducted an examination of 
aflatoxin uptake by the mycelium during the 4 h time-period. As shown in figure 4.3b, 
the percentage removal of aflatoxin per unit mass of mycelium by the end of 4 h was 
significantly higher for 48 h cultures than 24 h cultures. This data also agreed with the 
aflatoxin accumulation in the mycelia, which demonstrated a significantly higher 
accumulation of aflatoxin in 48 h cultures than in 24 h cultures. To examine whether the 
aflatoxin accumulation was a free diffusion versus an active uptake mechanism by the 
mycelium, we conducted a similar experiment with equal masses of dead AFS10 cultures 
obtained upon autoclaving the cultures. Our results demonstrate that while the free 
diffusion of aflatoxin from the medium to the immersed dead cells resulted in a faster 
removal of aflatoxin from the medium, the aflatoxin could not be retained in the dead 
mycelia unlike the live cells, when taken out of the medium and washed. Collectively the 
gradual increase in aflatoxin removal from the medium (unlike the dead cells) and the 
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ability of retaining the aflatoxin in the mycelium suggests an active uptake mechanism of 
aflatoxin by the cells. The significantly higher uptake of aflatoxin in 48 h cultures than 
the 24 h cultures suggest that the differential effects of the aflatoxin supplementation on 
total ROS in the 24 h versus 48 h cultures are associated with the differential levels of 
aflatoxin uptake by the mycelia of these ages. 
Finally, we also examined whether aflatoxin supplementation resulted in changes 
in the expression levels of the SOD genes either in 24 h or 48 h cultures. Contrary to the 
total ROS readings, there were no significant changes in SOD expression that were 
attributable to AF supplementation (figure 4.3c), thereby suggesting the possibility that 
aflatoxin supplementation induced changes in the total ROS are acute biochemical 
effects. 
4.5 DISCUSSION 
This study provides the first direct demonstration of the regulatory role of a 
secondary metabolite on a cellular process of the producer’s oxidative stress 
management. It also can now explain the previous reports on the cross-talk between 
oxidative stress and secondary metabolism (Jayashree et al., 2000; Narasaiah et al., 2006; 
Reverberi et al., 2006; Reverberi et al., 2008). Based on our current findings and 
previously published literature, we propose here a ROS management model for aflatoxin 
producers (illustrated in figure 4.4). According to this model, aflatoxin biosynthesis 
protects cells against ROS accumulation from at least three different sources: (a) primary 
metabolic processes, (b) secondary ROS generated from aflatoxin biosynthesis, as 
proposed previously by Roze et al. (Roze et al., 2015), and (c) ROS generated upon 
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aflatoxin uptake by cells during the stationary phase of growth (aflatoxin 
supplementation data from 48 h AFS10 cultures in the current study). The aflatoxin-
dependent protection occurs in one or a combination of the following ways: (a) utilization 
of ROS in the biochemical steps of the biosynthesis pathway (Narasaiah et al., 2006), (b) 
aflatoxin-dependent reduction of ROS in cells at exponential growth phase (aflatoxin 
supplementation data from 24 h AFS10 cultures in the current study) and (c) aflR-
dependent reduction of ROS (current study) possibly through its gene regulatory impacts 
outside the aflatoxin pathway gene cluster (Price et al., 2006; Yin et al., 2012). Our data 
support the likelihood that disruption of aflR blocks all the three modes of aflatoxin-
dependent protection, leading to a higher accumulation of super-oxide radicals in AFS10 
compared to SU-1. This can explain the increased demand for SOD activation and the 
higher SOD transcript levels in AFS10 than in SU-1. 
To address the direct effect of aflatoxin on total ROS, we designed a 4 h 
supplementation experiment to compare the individual effects of the supplementation on 
the 24 h and the 48 h AFS10 cultures. We understand based on previous literature (Roze 
et al., 2007; Banerjee et al., 2014; Chanda et al., 2009) that 24 h cultures and 48 h 
cultures (under our standard growth conditions), are very different physiological systems; 
24 h cultures demonstrate no secondary metabolite synthesis and in 48 h cultures 
secondary metabolite synthesis occurs at peak levels. The 4 h time was optimized from 
initial uptake experiments in which we noticed no significant increase in the growth of 
the mycelia until 4 h under the given experimental conditions (data not shown). We 
reasoned that supplementation beyond 4 h would result in adaptation of fungal cells and 
that would not allow us to observe the acute effects as described in this study. 
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It is speculated that fungal toxisomes, which are sites for the synthesis and 
compartmentalization of secondary metabolites (Chanda et al., 2009; Roze et al., 2011), 
receive input from peroxisomes and mitochondria as well as from the secretory and Cvt 
vesicle transport pathways (Roze et al., 2011). A significant increase in the mitochondrial 
SOD, MnSOD, at 48 h suggests that it is primarily responsible for dismutating the 
superoxides during the stationary phase. Previous proteomic data on fungal toxisomes in 
A. parasiticus (Linz et al., 2012) demonstrated an enrichment of superoxide dismutases, 
especially MnSOD, within the toxisomes as well. Catalases also present in the tosixomes 
then convert the hydrogen peroxide product of the dismutation reactions into oxygen and 
water. The data shown here correspond increased MnSOD with ROS levels after the 
initiation of aflatoxin biosynthesis support the possibility that superoxides are 
compartmentalized into fungal toxisomes in addition to the mitochondria, and become 
available for incorporation into secondary metabolite biosynthetic pathways, including 
aflatoxin synthesis, in addition to dismutation by SODs. We emphasize here that while 
the SOD expression profiles are closely and independently associated with total ROS and 
the activation of aflatoxin biosynthesis, our data (figure 4.3c) do not support aflatoxin as 
a direct regulator of SOD gene transcription, thereby suggesting that additional 
regulator(s) work in concert with AflR to regulate SOD gene expression. An example of 
such a regulator is the bZIP transcription factor AtfB (Roze et al., 2011; Wee et al., 
2017), which is in part one regulator of the SODs and the cellular response to 
intracellular oxidative stress (Hong et al., 2013; Hong et al., 2013; Wee et al., 2017) that 
binds to aflR gene promoter and physically interacts with the AflR (Miller et al., 2005; 
Roze et al., 2004). 
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One limitation of this study is the lack of an appropriate methodology for clean 
biochemical measurements specific for superoxide radicals (O2−) within Aspergillus cells. 
Commercially available small molecules like DMPO, that can successfully trap O2− 
within mammalian and yeast cells, have conventionally been used for such O2- 
quantifications. However, these small molecules fail to enter Aspergillus cells (data not 
shown). Within the cell, toxisomes are very dynamic systems that are continuously 
exporting protein and metabolite contents to the extracellular environment (Chanda et al., 
2010), at which time any present superoxide radicals would be detectable by molecules 
such as DMPO. Therefore, unless the extremely unstable O2− radicals are incorporated 
into the location of aflatoxin synthesis within toxisomes, as in case of SU-1 (but not in 
AFS10), commercial cellular stains like MitoSOX or CellROX cannot provide a true 
overall quantification of the total O2− radicals or total ROS through cellular imaging 
experiments as done for many mammalian cells, and will lead to inaccurate 
interpretations. The protocol used in these experiments is based on a methodology 
previously established by Chang et al. (Chang et al., 2011). The method allows the 
substrate DCFH-DA to react with the total ROS generated within mycelia and form the 
fluorescent marker DCF that can then be quantified spectrophotometrically. While we 
acknowledge the technical limitations of the DCFH-DA probe in providing an accurate 
quantification of superoxides and total ROS (Kalyanaraman et al., 2012), we reason that 
our experimental design, being dependent of relative ROS levels rather than accurate 
ROS quantifications, was able to circumvent these challenges and therefore our 
interpretations on relative ROS levels were not impacted. 
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In conclusion, our findings establish the foundation for a long-term study that will 
investigate the molecular, cellular, and biochemical mechanisms underlying the 
differential effects of aflatoxin on ROS accumulation in cells that are in an exponential 
growth phase versus those in a stationary phase. We hypothesize based on these findings 
that secondary metabolites have a regulatory role in the cellular coordination of 
secondary metabolism and oxidative stress response in filamentous fungi. Our future 
studies will shed more light on revealing the complexity of such coordination and thereby 
help identify novel targets for the manipulation of secondary metabolism. 
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Table 4.1: Amino acid sequences of the SODs analyzed in the study. The names of the 
SODs as annotated in the gene bank database and their accession numbers are mentioned 
above each sequence within the shaded rows. 
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Table 4.2: A bioinformatics analysis of the SOD annotated amino acid sequences. (A) 
Results from a search of the conserved domain signatures of SODs. Two sequences, 
CuZnSOD1 and MnSOD (shaded cells) show the typical SOD signatures. (B) (i) Results 
from a study of the detection of the most frequent patterns of the SODs available in the 
PROSITE database. A total of 390 SOD sequences were analyzed. The cells with the four 
most frequent patterns are highlighted in the table. (ii) Results from the analysis of the 
four most frequent patterns within the sequences (CuZnSOD cytosolic, FeSOD, 
FeSODA) that did not show conserved domain signatures.  
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Table 4.3: List of primers used in the study. 
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Figure 4.1: Decrease of total ROS during activation of aflatoxin biosynthesis. (a) 
Comparison of Figure 1. Decrease of total ROS during activation of aflatoxin 
biosynthesis. (a) Comparison of (i) aflatoxin accumulation and (ii) Gene expression 
levels relative to 24 h of three aflatoxin pathway aflatoxin accumulation and (ii) Gene 
expression levels relative to 24 h of three aflatoxin pathway genes in SU-1 and AFS10. 
(b) Comparison of total ROS at 24 h and 48 h. The error-bars represent genes in SU-1 
and AFS10. (b) Comparison of total ROS at 24 h and 48 h. The error-bars represent 
standard error of the mean. The two-tailed p-value was determined using unpaired t-test 
(GraphPad standard error of the mean. The two-tailed p-value was determined using 
unpaired t-test (GraphPad statistical software). #, Significant difference of transcript 
levels between 24 h and 48 h (p-value < 0.05, statistical software). #, Significant 
difference of transcript levels between 24 h and 48 h (p-value < 0.05, n = 3); * Significant 
difference of total ROS between SU-1 and AFS10 (p-value < 0.05, n = 3). 
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Figure 4.2: Comparison of SOD gene expression in SU-1 and AFS10. Quantitative PCR 
(qPCR) comparison of SOD gene expression in the two strains at 24 and 48 h of culture 
growth. All expression quantification were conducted in triplicate. For each gene the 
expression value was normalized against the 18s rRNA reference gene and compared to a 
beta-tubulin control. The expression values for each target gene at early stationary phase 
(48 h) were expressed as the fold change relative to 24 h time point. Fold changes ≥2.0 
were considered up- or down- regulated. All data and statistical analysis (Student’s t-test) 
were performed using CFX Manager software (Bio-Rad Laboratories). Compared to 24 h 
gene expression, FeSOD showed a significant decrease in both the wild-type (2.1-fold; p 
= 0.003) and AFS10 (3.9-fold; p < 0.001); FesodA showed no significant change for 
either strain; CuZnsod expression did not change in the WT, but showed a 2.1-fold 
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increase (p = 0.003) in AFS10; CuZnsod1 showed a large, significant decrease in 
expression for both the WT (22.4-fold; p = 0.001) and AFS10 (26.4-fold; p < 0.001); 
Mnsod had a dramatically significant 36.2-fold increase in gene expression in the WT (p 
< 0.001), and an even greater 69.8-fold increase in AFS10 (p < 0.001) compared 24 h 
expression. (Raw gene expression data is included as Figure 4.5). * Indicates statistically 
significant difference from respective 24 h gene expression; p ≤ 0.05. 
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Figure 4.3: Aflatoxin supplementation to AFS10. (a) Effect on total ROS. A quantitative 
comparison of ROS in AFS10 supplemented with 50 ppm aflflatoxin (in 70% methanol) 
and a 70% methanol control was conducted. Total ROS was quantiffiied at 24 h and 48 h 
of growth + 4 h of incubation in 1 µµM 20,70-dichlorofluorescein diacetate (DCFH-DA) 
in phosphate buffered saline (PBS) substrate with 2′,7′-dichlorofluorescein diacetate 
(DCFH-DA) in phosphate buffered saline (PBS) substrate with the the corresponding AF 
concentration. Error-bars represent SEM. (*) denotes statistically significant 
corresponding AF concentration. Error-bars represent SEM. (*) denotes statistically 
significant difference (p < 0.05; n = 3) in ROS compared to the 70% methanol control for 
the corresponding growth difference (p < 0.05; n = 3) in ROS compared to the 70% 
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methanol control for the corresponding time. (b) Cellular uptake of aflatoxin during 
aflatoxin supplementation. (i) Percent removal of aflatoxin growth time. (b) Cellular 
uptake of aflatoxin during aflatoxin supplementation. (i) Percent removal from the 
supplementation medium in live cells of 24 h and 48 h AFS10. The percent removal was 
of aflatoxin from the supplementation medium in live cells of 24 h and 48 h AFS10. The 
percent calculated at every hour until 4 h to compare the aflatoxin removal pattern by live 
cells with the dead removal was calculated at every hour until 4 h to compare the 
aflatoxin removal pattern by live cells cells that allow free diffusion from the medium 
into the cells. (ii) Percent aflatoxin accumulation in with the dead cells that allow free 
diffusion from the medium into the cells. (ii) Percent aflatoxin the mycelium of 24 h and 
48 h cultures. Aflatoxin in the mycelia of live cells was compared to the accumulation in 
the mycelium of 24 h and 48 h cultures. Aflatoxin in the mycelia of live cells was dead 
cells. Error-bars represent SEM. a, statistically significant difference (p < 0.05; n = 3) in 
aflatoxin compared to the dead cells. Error-bars represent SEM. a, statistically significant 
difference (p < 0.05; n levels with 0 h, b, statistically significant difference (p < 0.05; n = 
3) in aflatoxin levels between 24 h = 3) in aflatoxin levels with 0 h, b, statistically 
significant difference (p < 0.05; n = 3) in aflatoxin levels and 48 h cultures, c, statistically 
significant difference (p < 0.05; n = 3) in aflatoxin levels between between 24 h and 48 h 
cultures, c, statistically significant difference (p < 0.05; n = 3) in aflatoxin levels live and 
dead cells at a particular time-point. (c) Comparison of SOD gene expression in aflatoxin 
between live and dead cells at a particular time-point. (c) Comparison of SOD gene 
expression in supplemented and control AFS10. qPCR comparison of SOD gene 
expression in the control and 4 h aflatoxin supplemented and control AFS10. qPCR 
comparison of SOD gene expression in the control aflatoxin supplemented cells. The 
gene expression values were normalized against the 18s rRNA and 4 h aflatoxin 
supplemented cells. The gene expression values were normalized against the 18s 
reference gene. Fold changes 2.0 were considered up- or down-regulated. All data and 
statistical analysis (Student’s t-test) were performed using CFX Manager software (Bio-
Rad Laboratories). 
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Figure 4.4: Proposed model for total ROS management in A. parasiticus. Based on our 
current findings and previous reports we propose that aflatoxin-dependent protection 
occurs in one or a combination and previous reports we propose that aflatoxin-dependent 
protection occurs in one or a combination of the following ways: (a) utilization of ROS in 
the biochemical steps of the biosynthesis pathway (Narasaiah et al., 2006), (b) aflatoxin-
dependent reduction of ROS in cells at exponential growth phase (current study) of the 
following ways: (a) utilization of ROS in the biochemical steps of the biosynthesis 
pathway (b) aflatoxin-dependent reduction of ROS in cells at exponential growth phase 
(current study) and (c) aflR- dependent reduction of ROS (current study) possibly 
through its gene regulatory impacts outside the aflatoxin pathway gene cluster (Price et 
al., 2006; Yin et al., 2012). Aflatoxin dependent biochemical processes that sequester 
ROS still remain uncharacterized (green dashed arrow). Pink arrows indicate the sources 
of ROS accumulation. These include ROS generation from primary metabolic processes, 
secondary ROS generated from aflatoxin biosynthesis (Roze et al., 2015), and ROS 
generated upon aflatoxin uptake by cells during stationary phase of growth (based on 
aflatoxin supplementation data from 48 h AFS10 cultures in the current study). The 
mechanisms that result in ROS accumulation upon cellular uptake of aflatoxin remains 
uncharacterized (pink dashed arrow). The model can now explain the physiological need 
of the cells to co-regulate secondary metabolism (in this case, aflatoxin biosynthesis) and 
oxidative stress response through the bZIP proteins (Roze et al., 2011; Baidya et al., 
2014; Hong et al., 2013; Hong et al., 2013; Montibus et al., 2013; Reverberi et al., 2012; 
Montibus et al., 2015; Yin et al., 2013). Red arrows indicate the contributions of the 
current study. The molecular mechanism aflR-mediated regulation of SOD genes remains 
uncharacterized (red dashed arrow) and will be investigated in our follow up studies. 
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Figure 4.5: Raw expression data of the SOD genes in SU-1 and AFS10. qPCR 
comparison of SOD gene expression in the two strains at 24 h and 48 h of culture growth. 
All expression quantifications were conducted in triplicate. For each gene the expression 
value was normalized against and 18s rRNA reference gene and compared to a β-tubulin 
control  
1Gummadidala PM., Omebeyinje M., Deo T., Chanda A. To be submitted to Science. 
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CHAPTER 5 
Vibrio gazogenes: A NOVEL TOOL TO COMBAT THE PATHOGEN, 
Aspergillus flavus1 
 63 
5.1 ABSTRACT 
Aspergillus flavus is the most virulent and second most important Aspergillus 
species causing human infections ranging from hypersensitivity reactions to invasive 
infections (Hedayati et al., 2007). The Aspergillosis caused by A. flavus has a 90% 
mortality rate primarily due to the development of multi drug resistance. A. flavus also 
produces aflatoxins that contaminate food supplies globally and which when consumed 
lead to hepatocellular carcinoma. Biological controls were proven to be most effective in 
inhibiting aflatoxins and aflatoxin producing fungi. Vibrio gazogenes was proven to 
synthesize antifungal and antiaflatoxin metabolites. In this study we treated A. flavus 
cultures with 16 million V. gazogenes cells and observed >99% significant decrease in 
aflatoxin levels in the first generation and ~40% decrease of aflatoxin levels in the second 
generation of A. flavus cultures. The dead and live V. gazogenes cells have similar 
aflatoxin inhibitory effects that were specific to V. gazogenes and not to other gram-
positive or gram-negative bacterium. Infecting corn kernels with A. flavus in the presence 
of bacterium significantly decreased the fungal conidial growth by 80% and aflatoxin by 
>98%. Treating drosophila flies with V. gazogenes prior to A. flavus infection increased 
their survival (~40%). Using confocal laser, scanning electron and transmission electron 
microscopies we observed the uptake of the bacterium by the fungus into endosome like 
compartments. RT-PCR data revealed controversial gene expressions of aflatoxin 
pathway genes and global secondary metabolite regulatory genes in the presence of live 
and dead V. gazogenes. These data suggest that the live and dead V. gazogenes aflatoxin 
inhibitory mechanisms are different. The data also uncover the yet unstudied concept that 
V. gazogenes mechanism of aflatoxin inhibition is not at the gene level but is at the 
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cellular level. Finally our study has discovered a novel tool (Vibrio gazogenes) to inhibit 
the aflatoxin production and pathogenicity of plant and human pathogen Aspergillus 
flavus. 
5.2 INTRODUCTION 
The fungus Aspergillus flavus is a saprophyte, growing in humid environments 
with pathogenic ability causing aspergillosis in immuno-compromised humans effecting 
the skin, oral mucosa and subcutaneous tissues (Hedayati et al., 2007). Furthermore, A. 
flavus is the most virulent and second most important Aspergillus species causing human 
infections ranging from hypersensitivity reactions to invasive infections (Hedayati et al., 
2007). According to the centers for disease control and prevention (CDC) approximately 
4.8 million cases of aspergillosis were diagnosed worldwide and A. flavus is the second 
most leading cause. Most A. flavus strains are susceptible to antifungal therapy but the 
minimum inhibitory concentrations are atleast two fold higher than for other Aspergillus 
species (Krishnan et al., 2009). Furthermore, recent discoveries revealed the presence of 
active multi drug resistant genes in A. flavus strains increasing their potential for drug 
resistance and increased pathogenicity (Tobin et al., 1997) (Van Der Linden et al., 2011). 
A. flavus is also a plant pathogen and releases aflatoxins that are secondary 
metabolites and aflatoxin B1 had been categorized as class 1A human carcinogen by the 
International Agency of Research on Cancer (IARC). Aflatoxins contaminate a wide 
range of crops, produce, food, nuts, cereal, milk, juices, homes, wood, etc., and can be 
ingested into intestines and enter systemic circulation causing aflatoxicosis and liver 
cancer. Aflatoxin B1 synthesized by A. flavus is extremely stable (Garcia et al., 1994) at 
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temperatures greater than 150OC maintained for 30 minutes (Raters and Matissek 2008) 
and so cannot be detoxified by cooking or autoclaving. Therefore aflatoxins pollute many 
food groups that are ingested by humans and animals. Most common methods used in 
agriculture to reduce aflatoxin contamination are expensive, time consuming and have 
low efficiency with limited success rates. Novel therapies are required to fight against A. 
flavus strains and inhibit both its pathogenicity and aflatoxin production without affecting 
the host physiology. In their zeal to find new anti-fungal and anti-aflatoxin agents 
scientists have turned towards plant and microbe derived compounds especially from 
organisms that live in aflatoxin induced environments (Holmes et al., 2008). 
Vibrio gazogenes is a marine gram-negative bacterium notoriously known for its 
synthesis of antifungal pigments (Darshan and Manonmani 2015). Studies have shown 
that when V. gazogenes comes in contact with aflatoxin, the toxin induces V. gazogenes 
to synthesize antifungal and anti-aflatoxin metabolites termed aflatoxin responsive 
metabolites (ARMs). ARMs are responsible for decreasing 60% of aflatoxin by inhibiting 
the aflatoxin biosynthetic pathway at the gene level (Gummadidala et al., 2016). But 
various studies have shown that when the bacterium and fungus (A. flavus or A. 
parasiticus) have been co-cultured then the aflatoxin production was inhibited by greater 
than 95% (Chang and Kim 2007, Wang et al., 2013). Also Lactobacillus pentosus and 
Lactobacillus beveris bacteria have been successfully used to eliminate aflatoxin B1 from 
contamination of milk via the binding of aflatoxin B1 to the bacteria (Hamidi et al., 
2013). 
These studies have prompted us to hypothesize that co-culturing V. gazogenes 
bacterium with A. flavus fungus will have significant inhibitory effects on the aflatoxin 
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biosynthesis of A. flavus. In this study, we treated A. flavus with live and dead V. 
gazogenes cells and observed the decrease in aflatoxin with no effect on fungal mycelial 
growth. We further conducted microscopic imaging and observed the uptake of V. 
gazogenes into endosome like compartments in A. flavus. To understand the mechanism 
of action of V. gazogenes we performed transcript accumulation analysis and surprisingly 
concluded that V. gazogenes aflatoxin inhibitory activity is not at the gene level but 
possibly at the cellular level. Finally our tests to understand the effect of V. gazogenes on 
pathogenicity of A. flavus reveal the decrease of aflatoxin and conidial formation in corn 
and increase of survival in drosophila that were infected with A. flavus. Definitively we 
report the discovery of a novel tool (V. gazogenes) to combat the aflatoxigenicity and 
pathogenicity of A. flavus. 
5.3 METHODS AND MATERIALS 
5.3.1 Strains, media and growth conditions 
The fungus Aspergillus flavus strain CA14PyrG.1 (acquired from USDA) and 
bacteria Vibrio gazogenes (ATCC29988), Staphylococcus aureus (ATCC), and 
Escherichia coli (ATCC) were used for this study. Yeast extract sucrose (YES) (2% 
yeast extract, 6% sucrose; pH 5.8) was used as the liquid growth medium and potato 
dextrose agar (PDA) and YES agar (YESA) were used as the solid growth media, for A. 
flavus. Fungal cells were grown for 72 h (as required by experiments) by inoculating 
0.5x106 spores per 50 mL of liquid growth medium and incubated at 29°C in a dark 
orbital shaker at 150 rpm. For growth of fungal mycelia on solid media, 2x104 spores 
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were center inoculated on 100 mm petri dishes containing 10 mL of PDA/YESA and 
incubated in the dark at 29°C. 
Difco Marine broth (cat # 2216, BD Biosciences, Sparks, MD) was used, as liquid 
growth media for V. gazogenes and the bacterial cells were grown for 24 h by inoculating 
105 colony forming units (cfu) /100 ml of growth medium. The cultures were incubated at 
29°C in a dark orbital shaker at 150 rpm. Tryptic soy broth (TSB, cat # 211822, BD 
Biosciences, Sparks, MD) was used as liquid growth media for S. aureus, and E. coli. 
Small inoculum were grown with 105 cfu/5 ml liquid growth media and incubated 
overnight at 37°C in a dark orbital shaker at 150 rpm. At the end of the incubation time, 
100,000 cells were taken from the small inoculum and further used to inoculate 100 ml 
TSB and incubated for 24 h at 37°C in a dark orbital shaker at 150 rpm. 
5.3.2 A. flavus treatment with V. gazogenes, S. aureus, and E. coli 
The fungus A. flavus was treated with both live (V. gazogenes) and dead bacteria 
(V. gazogenes, S. aureus, and E. coli). The 24 h bacterial cultures were spun down at 
4000 rpm for 15 min at room temperature and resuspended using YES media. With the 
help of absorbance measurements at 600 nm, 4, and 16 million cells from a 24 h bacterial 
culture (live or made unviable by boiling at 100OC for 10 min in a hot plate) were sorted 
out and added to the 50 ml YES liquid media simultaneous with 5x105 A. flavus spores 
and incubated at 29°C in a dark orbital shaker at 150 rpm for 24 h, 48 h and 72 h. At the 
end of incubation, A. flavus mycelia were harvested by filtering the mycelia through a 
miracloth (Millipore, Billerica, MA) and the cells subjected to appropriate processing for 
various growth measurements, aflatoxin analysis and gene expression analysis. 
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Comparably 4 or 16 million V. gazogenes cells (viable or unviable) were spread 
out as a monolayer on the YESA or PDA 10 cm media plates. The bacterial cells were 
allowed to dry in the biosafety cabinet and 2x104 spores of A. flavus were center 
inoculated. The hyphal growth of the fungus was recorded daily and at the end of the 
incubation period the YES and PDA media was chopped up and used appropriately for 
further processing of aflatoxin analysis. 
5.3.3 Growth measurements of A. flavus, V. gazogenes, S. aureus, and E. coli 
All fungal growth in liquid media was quantified by using dry weight 
measurements. Briefly, the mycelia were filtered out of the growth media using a 
miracloth (Millipore, Billerica, MA) and dried in an oven at 80°C for 6 h and the weight 
difference before and after drying was recorded. To estimate growth of A. flavus on PDA 
and YESA media plates, the spread of mycelial colony was measured daily. After 9 days 
of incubation time, spores were manually collected from PDA plates using 1xPBS with 
0.01% tween and resuspended in 50% glycerol. Spores were counted using 
haemocytometer. All bacterial growth measurements were performed using absorbance 
readings of growth media at 600 nm. An absorbance of 1.2 on the UV/Vis 
spectrophotometer was considered as 106 cells/ml bacterial cellular density and 
calculations were performed for 4 and 16 million bacterial cells appropriately. 
5.3.4 Aflatoxin measurements 
5.3.4.1 Aflatoxin ELISA analysis 
Aflatoxin was extracted from A. flavus cultured YES liquid media by adding 
equal volume of chloroform in a separating funnel and collecting the organic layer. 
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Chloroform was evaporated from the organic layer and the residual aflatoxin was 
resuspended in 1 ml of 70% methanol. Aflatoxin was extracted from A. flavus cultures 
grown in/on YES and PDA media plates by chopping the agar media and vigorously 
shaking it with equal volume of chloroform. Again the chloroform layer was collected, 
evaporated and the residual aflatoxin was resuspended in 1 ml of 70% methanol. The 
resuspended aflatoxin extract was spun down at 15,000 rpm for 1 min at room 
temperature to remove extra debris from the media and mycelia. The clear aflatoxin 
extract was used for analyzing aflatoxin using the Neogen Veratox Aflatoxin ELISA kit 
(cat # 8030) from Neogen (Lansing, MI, USA) and measured on a Stat Fax 4700 
Microstrip Reader (Awareness Technologies, Palm City, FL, USA) as per kit’s protocols. 
The ELISA has 2 ppb and 50 ppb as lower and upper limits of detection respectively. 
Therefore highly concentrated aflatoxin samples were diluted to fit within the detection 
range. 
5.3.4.2 Metabolite analysis using UPLC system 
The Food and Feed Safety Research Unit at USDA performed metabolite analysis 
using UPLC (Ultra high pressure liquid chromatography). Cultures of A. flavus 
(with/without V. gazogenes) (50 ml) were lyophilized and then extracted twice with 5% 
methanol / 95% ethyl acetate + 0.1% formic acid (15 ml) overnight with shaking at room 
temperature. The 2 extractions were pooled and concentrated in vacuo. The dried extract 
was redissolved in methanol at 5 mg/ml and centrifuged (14,000 rpm, 2 min) to remove 
particulate prior to analysis. Samples were analyzed using a Waters Acquity UPLC 
system (40% methanol in water, BEH C18 1.7 µm, 2.1 x 50 mm column) using 
fluorescence detection (Ex= 365 nm, Em= 440 nm). Samples were diluted 10-fold if the 
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aflatoxin signal saturated the detector. Analytical standards (Sigma-Aldrich, St. Louis, 
MO) were used to identify and quantify aflatoxin B1 (AFB1, retention time = 4.60 min.). 
Aflatoxin concentrations are expressed in ng aflatoxin / ml culture or ng aflatoxin / g 
mycelium. 
Simultaneously samples were also analyzed for Cyclopiazonic acid, on a Waters 
Acquity UPLC system using PDA UV and Qda mass detection with the following 
gradient solvent system (0.5 ml/min, solvent A: 0.1% formic acid in water; solvent B: 
0.1% formic acid in acetonitrile): 5% B (0-1.25 min.), gradient to 25% B (1.25-1.5 min.), 
gradient to 100% B (1.5-5.0 min.), 100% B (5.0-7.5 min.), then column equilibration 5% 
B (7.6-10.1 min.). Cyclopiazonic acid was identified using an authentic standard 
purchased from Sigma Aldrich (CPA, retention time = 4.10 min, M+H = 337.2 m/z). CPA 
concentrations are expressed in ng CPA / ml culture or ng CPA / g mycelium. 
5.3.5 RNA extraction, purification and cDNA synthesis 
Total RNA was extracted from fungal cells harvested using a TRIzol-based (TRI 
Reagent®; cat # T9424, Sigma, Carlsbad, CA, USA) method. The harvested mycelia 
were ground with a mortar and pestle in liquid nitrogen. The cold powdered mycelia was 
mixed with TRI Reagent® and chloroform and the mix was spun down at 10,000 rpm for 
10 min at room temperature. The organic layer was mixed with equal volumes of 
isopropanol and incubated on ice for 15 min and later centrifuged at 10,000 rpm for 15 
min at room temperature. The precipitated crude RNA was washed with 70% ethanol and 
resuspended in RNAse/DNAse free water (Sigma, Carlsbad, CA, USA). Within 24 h of 
extraction, RNA cleanup was performed using a Qiagen RNEasy Cleanup Kit (Qiagen, 
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Valencia, CA, USA), as per kit’s instructions and samples were stored at −80°C. Total 
RNA was then reverse transcribed to cDNA using iScript™ cDNA Synthesis Kit 
(BioRad Laboratories, Hercules, CA, USA) as per kit’s instructions. All samples were 
checked for concentration and purity after each step using a NanoDrop 2000 
Spectrophotometer (Thermo-Fisher Scientific, Waltham, MA, USA). All cDNA samples 
were stored at −20°C until subsequent RTPCR quantification. 
5.3.6 Quantitative PCR Assays 
Expression of global secondary metabolism genes (laeA, veA, AtfB), aflatoxin 
pathway genes (aflR, nor-1, ver-1), pathogenic genes (SAP) and superoxide dismutase 
(SOD) genes (MnSOD, CuZnSOD) was examined by quantitative PCR assays (qPCR) 
using SsoAdvanced Universal SYBR Green Supermix (BioRad Laboratories, Hercules, 
CA). Gene specific forward and reverse primers were designed using Primer3 online 
software (Ye et al., 2012). Reactions were performed as per BioRad SYBR Green 
protocol guidelines and quantified using a CFX96 thermal cycler (Bio-Rad Laboratories, 
Hercules, CA, USA). All RT-PCRs were performed in triplicate for each gene per 
sample. The 18s ribosomal DNA was used as a reference gene in the gene analysis. The 
gene expression values of A. flavus obtained from the threshold cycle values were 
normalized to the 18s rDNA of each sample. We choose 24, 30 and 40 h to study the 
transcripts of the genes (explained later in results). For quantitative comparison of gene 
expressions, the values for each target gene at 30 h and 40 h were expressed as fold 
change relative to the 24 h time point of that specific treatment condition. Data analysis 
was performed using CFX Manager software (Version 3.1, Bio-Rad Laboratories, 
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Hercules, CA, USA, 2012). Significant change in gene expression was considered if fold 
change was ≥ 2 and p-value was < 0.01. 
5.3.7 Imaging of fungus and bacteria 
5.3.7.1 Confocal microscopy 
A. flavus was grown on a cover slip and treated with V. gazogenes for 6 h. The 
fungal mycelia were fixed using 4% formaldehyde and washed using 1xPBS and 0.05% 
tritionX-100. The resulting mycelia were studied and imaged using Leica TCS SP5 
confocal microscope at 20x magnification. 
5.3.7.2 Scanning electron microscopy 
A. flavus was treated with 16 million live V. gazogenes cells for 48 h in YES 
liquid medium and the mycelia were harvested and fixed using 3% glutaraldehyde and 
2% osmium tetroxide, dehydrated in ethyl alcohol, and dried using LADD critical point 
dryer. Samples were later coated with gold using Denton Vacuum Desk II sputter coater. 
The coated samples were loaded onto TESCAN Vega-3 SBU scanning electron 
microscope and studied at 17k magnification to understand the effect of V. gazogenes by 
A. flavus hyphae. 
5.3.7.3 Transmission electron microscopy 
Briefly A. flavus was treated with 16 million live V. gazogenes cells for 48 h in 
YES medium. Mycelia were harvested, fixed using 3% glutaraldehyde and 2% osmium 
tetroxide, dehydrated in ethyl alcohol, and made into blocks using resin mix. The resin 
blocks were trimmed and cross-sectioned into 80 nm thick sections using a diamond 
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knife (Micro Star Technology Inc., Huntsville, Texas) loaded onto a Sorvall Porter-Blum 
MT2-B Ultra-Microtome. The sections were loaded onto copper grids, and later stained 
with lead stain and 5% uranyl acetate. The stained grids were then loaded onto Hibachi 
H8000 scanning transmission electron microscope. Pressure was maintained at 10-7 Torr, 
accelerating voltage at 200kV and images were taken at low magnification (10,000x) and 
at high magnification (20,000x) and the localization of the bacterium in A. flavus cells 
was studied. 
5.3.8 Corn treatments 
Corn kernels were infected with A. flavus in the presence and absence of live V. 
gazogenes. Briefly fresh commercial packaged corn was bought from grocery store and 
kernels were separated. The kernels were then poked with a toothpick or needle to make a 
microscopic hole to mimic an insect bite. 10 kernels were placed in each set and 3 sets 
were in each treatment condition – corn with no infection (negative control), corn with V. 
gazogenes (positive control for bacteria), corn with only A. flavus (positive control for 
fungal infection), and corn with A. flavus and live V. gazogenes (the treatment set). A 
monolayer of 400,000 live V. gazogenes cell suspended in YES media was applied to the 
kernels and semi dried. 10,000 A. flavus spores were inoculated on top of the bacterial 
layer for the treatment conditions. Microscopic images using a Leica dissection 
microscope were taken to observe and record the effect of V. gazogenes on A. flavus 
infection. The percentage of infection was estimated (after 48 h of incubation) by 
comparing the number of infected kernels in the presence and absence of V. gazogenes. 
After 5 days of incubation the kernels were ground in chloroform and filtered. The filtrate 
was evaporated and residual extract was rinsed out with 100% methanol. Methanol was 
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evaporated and extracted aflatoxin was resuspended in 1 ml of 70% methanol. The 
resuspended aflatoxin extract was spun down at 15,000 rpm for 1 min at room 
temperature to remove extra debris from the corn and mycelia. The clear aflatoxin extract 
was used for analyzing aflatoxin using the Neogen Veratox Aflatoxin ELISA kit (cat # 
8030) from Neogen (Lansing, MI, USA) and measured on a Stat Fax 4700 Microstrip 
Reader (Awareness Technologies, Palm City, FL, USA) as per kit’s protocols. The 
ELISA has 2 ppb and 50 ppb as lower and upper limits of detection respectively. Thus 
highly concentrated aflatoxin samples were diluted to fit within the detection range. 
5.3.9 Drosophila fly treatment 
Drosophila melanogaster female flies of 3-5 days old were treated with A. flavus 
in the presence and absence of live V. gazogenes and the survival of the flies were 
recorded. Method used was published by Ramírez-Camejo et al., in 2014. Drosophila 
flies were anaesthetized using carbon dioxide and placed on a PDA 10 cm agar plate 
containing A. flavus colony with spores. The flies were rolled on the plates by agitation 
for 1 min to make them inoculated and then transferred to tubes containing food. (To 
quantify the number of spores, the inoculated flies were vortexed in sterile water 
containing 0.01% Tween 80 and centrifuged to spin down the spores, which were then 
counted using haemocytometer – 2 to 4 x104 spores attached/fly). The flies were 
transferred to fresh media tube after 1 h to loose any extra spores. For control or 
untreated fly treatments 25 flies per tube of 3 tubes were used. For V. gazogenes 
treatments 29 flies per tube of 3 tubes were used. For V. gazogenes treatments the 
drosophila flies were starved for 8 h and then given feed containing V. gazogenes for next 
24 h. The flies were anaesthetized using carbon dioxide and rolled on PDA 10 cm plates 
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grown with A. flavus similar to the control flies. These infected flies were placed back on 
V. gazogenes containing feed and the feed was replaced with fresh feed containing V. 
gazogenes every 24 h. At the end of 7 days the survival of the flies as compared to 
controls (negative control had no A. flavus infection and positive control had A. flavus 
infection but no V. gazogenes) was observed and recorded. 
5.3.10 Statistical analysis 
All experiments were performed in triplicate. Microsoft Excel was used to 
generate graphs, perform statistical analysis and calculate significance for dry weight 
measurements and aflatoxin analysis. Significance was considered when p value was less 
than 0.01. RT-PCR statistical analysis was performed using CFX manager software with 
parameters set for significance at p-value <0.01 and gene expression fold change ≥ 2. 
5.4 RESULTS 
5.4.1 V. gazogenes inhibits aflatoxin production of A. flavus without effecting growth of 
the fungus 
To understand the effect of V. gazogenes on A. flavus growth and aflatoxin 
synthesis, we initially performed a dose response of multiple cellular concentrations of V. 
gazogenes on A. flavus. The fungus was treated with 4 and 16 million V. gazogenes cells 
in YES liquid media for 48 h. The dry weight analysis at the end of the incubation period 
revealed that the mycelial growth of A. flavus did not differ with either 4 or 16 million V. 
gazogenes cells as compared to the untreated control (Figure 5.1a). On the other hand, the 
aflatoxin levels analyzed using ELISA technique show that there were nearly 
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undetectable levels of aflatoxin in the YES liquid media in the presence of V. gazogenes 
(irrespective of cellular concentration) as compared to the untreated control (Figure 5.1b). 
Most surfaces in the environment on which A. flavus thrives are solid. Thus we 
performed similar experiments on YESA solid media. A. flavus was treated with different 
bacterial cellular concentrations of 4 and 16 million V. gazogenes cells on the YESA 
media plates and the spread of the fungal colony on the media was measured and 
recorded daily. The graph in figure 5.1c reveals that V. gazogenes decreases the A. flavus 
growth by 25% regardless of the bacterial cellular concentration. Aflatoxin analysis at the 
end of 9 days of incubation showed that 16 million V. gazogenes cells significantly 
decreased aflatoxin production to nearly undetectable levels where as 4 million V. 
gazogenes cells only made a 25% difference as compared to the untreated control (figure 
5.1d). 
These data clearly state that 16 million V. gazogenes cells consistently and 
significantly decrease aflatoxin production (>99%) in both solid and liquid media. The 
aflatoxin inhibitory effect of 16 million V. gazogenes cells was further validated by 
UPLC (table 5.2). The ultra HPLC shows the complete loss of aflatoxin B1 and aflatoxin 
B2 by A. flavus during V. gazogenes treatments. We also observed the complete loss of 
Cyclopiazonic acid (another major mycotoxin belonging to ergoline alkaloids) of A. 
flavus during V. gazogenes treatments. Accordingly for further experimentation we 
choose to use 16 million V. gazogenes cells. 
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5.4.2. V. gazogenes decreases A. flavus aflatoxin production over time 
To understand the effect of V. gazogenes on aflatoxin production beyond the 
normal 48 h, we treated A. flavus (in YES liquid media) with 16 million V. gazogenes 
cells for 72 hours, collecting media and mycelia at 24, 48 and 72 h time points. Dry 
weight analysis revealed the no difference in the growth of the fungi between treated and 
untreated samples (figure 5.2a) for that specific time point. On the other hand the 
aflatoxin analysis revealed that V. gazogenes decreases aflatoxin to undetectable levels 
even at 72 h time point (figure 5.2b). The data shows that the aflatoxin inhibitory effect 
of V. gazogenes does not stop at the early stationary phase (48 h) where the fungal cells 
were thriving but also that the V. gazogenes effectively inhibits aflatoxin when the fungal 
cells were over crowded and starting to form a biofilm (72 h). 
5.4.3 V. gazogenes aflatoxin inhibitory effect was carried on to the second generation of 
A. flavus 
The classical potato dextrose agar media was used to study the growth of A. flavus 
spores in the presence of V. gazogenes. Two different bacterial cellular concentrations of 
4 and 16 million V. gazogenes cells were spread on the agar plate and fungal colony 
growth was observed for 9 days. Observation of the growth of fungal biofilm in the 
presence of the bacterium tells us that the growth was significantly slower in the 
beginning but eventually catches up to the control with no bacteria (figure 5.3a). The 
aflatoxin analysis shows the same pattern of aflatoxin inhibition (~75% for 4 million cells 
and undetectable levels for 16 million cells) in the presence of V. gazogenes (figure 5.3b). 
But surprisingly the spore count for the fungal colony in the presence of 16 million cells 
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was >50% as compared to its no bacterial control (figure 5.3c). The gram-negative 
bacterium V. gazogenes encourages spore generation in A. flavus. 
To test the viability and aflatoxin inhibitory effects of the spores generated in the 
presence of V. gazogenes, we collected the spores from bacterial treated (4 and 16 million 
cells) fungal colonies and re-plated/inoculated them on fresh PDA plates. We called these 
the second-generation spores. The second-generation spores had growth pattern and spore 
formation similar to controls (figure 5.3d). The second-generation spores generated from 
4 million bacterial cells treated fungi did not carry on the aflatoxin inhibitory 
characteristics but the spores generated from the 16 million bacterial cells treated fungi 
inhibited aflatoxin by 40% (figure 5.3e). Surprisingly the second-generation spores 
carried their aflatoxin inhibition characteristics. This tells us that the V. gazogenes 
aflatoxin inhibitory effects can be carried through generations. 
5.4.4 Dead V. gazogenes cells inhibit aflatoxin levels in A. flavus 
Dead bacterial biomass had proven to be better and safer bioadsorbent for 
contaminants in the environment and is much preferred due to lack of nutrients and 
cultural conditions (Zeroual et al., 2006). To test the supposition that dead V. gazogenes 
cells were equally capable of decreasing aflatoxin levels in A. flavus cultural media, we 
boiled the bacteria at 100OC for 10 min in a hot plate to make them unviable. (Bacterial 
cells were tested by inoculation into fresh marine broth media and observed for growth 
using spectrophotometric analysis over the next 48 h and confirmed the no growth of the 
V. gazogenes cells). 4 and 16 million dead V. gazogenes cells were used to treat A. flavus 
and the mycelial growth and aflatoxin synthesis were observed. After 48 h the fungal 
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mycelial mass did not change (regardless of bacterial cellular concentrations) but the 
aflatoxin levels significantly decrease with 16 million dead V. gazogenes cells (figure 
5.4) similar to live V. gazogenes cells. The UPLC data in table 5.2 shows that dead V. 
gazogenes cells cause complete loss of aflatoxin B1, aflatoxin B2 and cyclopiazonic acid 
similar to live V. gazogenes cells. This shows us that the unviable and viable V. 
gazogenes cells equally inhibit mycotoxin production. 
5.4.5 Aflatoxin inhibition of A. flavus is specific to V. gazogenes 
To understand if the aflatoxin inhibitory effect was limited to V. gazogenes, we 
treated A. flavus with a gram-positive bacterium, Staphylococcus aureus and a gram-
negative bacterium, Escherichia coli and analyzed the fungal growth and aflatoxin levels. 
16 million dead bacterial cells were added to A. flavus and the fungus was harvested after 
72 h. Dead bacteria cells were used to reduce the pathogenic interaction between the A. 
flavus, S. aureus and E. coli. The growth of the A. flavus did not change in the presence 
of either S. aureus or E. coli and the aflatoxin levels did not show any significant change 
either (figure 5.5). This data points out that there is a high possibility that the aflatoxin 
inhibitory effect of V. gazogenes is exclusive to itself.  
5.4.6 A. flavus uptake of V. gazogenes 
Bacterial-fungal interactions exist via various physical associations. In the 
bacterial-fungal biofilms, one form of association is the internalization of bacteria by 
fungi altering the fungal physiology (Frey-Klett et al., 2011). V gazogenes synthesizes 
prodigiosins, which are red in color giving the bacterial cells a red color. A. flavus 
cultures (colorless or white) in YES liquid medium were treated with live V. gazogenes 
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(red color) and every 6 h the bacterial presence in YES was observed and recorded using 
spectrophotometry reading at 600 nm. We observed that the V. gazogenes optical density 
decreased over time and the fungal mycelia turned reddish pink (as attributed to the red 
pigment in the bacterial cells). The figure 5.6a shows that over a time period of 42 h the 
bacteria were completely depleted from the YES media and the media turned back to its 
original yellow. To understand the interactions between A. flavus and V. gazogenes we 
fixed A. flavus hyphae in the presence of live V. gazogenes and studied them using a 
Leica confocal microscope. At 20x magnification we observed the presence of bacteria 
inside the fungal walls (figure 5.6b) confirming the uptake of V. gazogenes by A. flavus 
hyphae. 
5.4.7 Live V. gazogenes increases aflatoxin biosynthesis pathway genes of A. flavus over 
time 
Previously, Gummadidala et al (Gummadidala et al, 2016) had shown that V. 
gazogenes metabolites decrease aflatoxin biosynthesis by inhibiting the aflatoxin genes. 
After understanding the effect of V. gazogenes on growth and aflatoxin production of A. 
flavus and observing the uptake of V. gazogenes by A. flavus hyphae, we hypothesized 
the aflatoxin inhibitory effect was happening at the transcript level. A quantitative 
comparison of transcript accumulation of two aflatoxin genes (nor-1 and ver-1) and the 
aflatoxin pathway regulator gene (aflR) was performed. Norsolorinic acid is the first 
stable compound in the 17-step aflatoxin biosynthesis pathway, which is synthesized by 
the Nor-1 reductase enzyme that is encoded by nor-1 gene (Jiujiang Yu, 2012). 
Versicolorin A (VER A) is the last compound synthesized prior to the making of the 
intermediates that lead to the final aflatoxin products. VER A is converted to the first 
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intermediate by a reductase, Ver-1 that is encoded by ver-1 gene (Jiujiang Yu, 2012). The 
aflatoxin biosynthesis genes get activated by 24 h with transcript accumulation at 30 h 
and by 40 h the fungus is producing copious amounts of aflatoxin in YES liquid growth 
media (Roze et al., 2007a). Thus we choose 24, 30 and 40 h to study the transcripts of 
nor-1, ver-1 and aflR genes. The 30 h and 40 h samples were compared to the 24 h 
sample of that specific treatment condition to calculate relative fold change in gene 
expressions. Figure 5.7 shows 3 graphs of fold change of aflR, nor-1 and ver-1 gene 
expressions. The aflR (2-3 fold change), nor-1 (3-7 fold change) and ver-1 (2-9 fold 
change) gene expressions of untreated control samples of A. flavus were significantly 
upregulated from 24 h to 40 h, which is in accordance with multiple published studies. 
The aflR (~7 fold change), nor-1 (~25 fold change) and ver-1 (14-17 fold change) gene 
expressions of live V. gazogenes treated samples of A. flavus were significantly 
upregulated from 24 h to 40 h as compared to their specific controls. On the contrary the 
for the A. flavus treated with dead V. gazogenes cells, aflR, and nor-1 show no significant 
change and ver-1 decreased at 30 h and increased at 40 h to reach get back to the regular 
levels. The data leads us to hypothesize that the V. gazogenes aflatoxin inhibitory 
mechanism is different for live and dead V. gazogenes cells. The compilation of the data 
shows that both live and dead V. gazogenes cells decrease aflatoxin but do not inhibit the 
aflatoxin pathway genes. This leads to the conclusion that the aflatoxin inhibitory effect 
of V. gazogenes was not occurring by regulation of the aflatoxin pathway genes. 
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5.4.8 Effect of V. gazogenes on global secondary metabolism regulatory genes of A. 
flavus 
The two global secondary metabolism regulatory genes laeA and veA have been 
found to be involved in regulation of aflatoxin synthesis in A. flavus and the deletion of 
these genes leads to complete loss of aflatoxin (Cary et al., 2018). To understand if any of 
the upstream positive or negative regulators of aflatoxin pathway were affected we 
studied the transcript accumulation of laeA, veA and AtfB in the presence of live/dead V. 
gazogenes cells at the 24 h, 30 h and 40 h time points of A. flavus growth (figure 5.8). 
The 30 h and 40 h samples were compared to the 24 h sample of that specific treatment 
condition. The live V. gazogenes cells inhibit the laeA and increase the veA gene 
expressions from a 24 h to 40 h time period, which was opposite to what happened in the 
untreated control samples. laeA is a negative regulator of veA (Amaike and Keller 2009) 
so its not surprising that one transcript accumulation increases while the other deceases. 
The pattern of laeA and veA gene expression was similar during dead V. gazogenes 
treatments with increase in their gene expression at 40 h time point. We would like to 
point out once again that the pattern of gene expression is not explaining the decrease in 
aflatoxin levels. This draws the conclusion that live or dead V. gazogenes aflatoxin 
inhibitory effect is not due to regulation of aflatoxin pathway genes or global secondary 
metabolite regulatory genes. Rather the bacterial inhibitory effect might be at the cellular 
level. 
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5.4.9 V. gazogenes was endocytosed into endosomal like compartments by the A. flavus 
To understand the effect of V. gazogenes on A. flavus at a cellular level we used 
electron microscopy to study the surface (SEM) and inside (TEM) of the fungal hyphae 
in the presence of live V. gazogenes cells. The scanning electron microscope (SEM) 
pictures in figure 5.9 shows images of the surface of A. flavus hyphae untreated/treated 
with live V. gazogenes cells. At 17k magnification the wrinkled effected surface of V. 
gazogenes treated hyphae can be appreciated. The SEM magnified image of the treated 
hyphae shows the entry of the bacteria (yellow arrows) into the A. flavus probably via 
endocytosis like process. The transmission electron microscopy (TEM) pictures in figure 
5.10 illustrate cross-sectional images of the A. flavus hypha exposing different internal 
cellular structures. The 10k and 20k magnified TEM images show the presence of the V. 
gazogenes in endosomal like compartments (white arrows) in the A. flavus hypha. 
Similarly uptake of nano particles by fungi also altered the fungal physiology by 
decreasing aflatoxin biosynthesis (Mitra et al., 2017). These microscopic images state 
that V. gazogenes enter the A. flavus hyphae leading to decrease in aflatoxin biosynthesis. 
Therefore we state that the V. gazogenes aflatoxin inhibitory effect was happening at the 
cellular level. 
5.4.10 Effect of V. gazogenes on SOD genes 
Previous studies in our lab support the hypothesis that reactive oxygen species 
output is regulated by aflatoxin biosynthesis (Keene et al., 2018). To understand the 
cellular processes involved in aflatoxin inhibitory effect of V. gazogenes we studied the 
genes involved in reactive oxygen species (ROS) regulation. Superoxide dismutases are 
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synthesized in response to reactive oxygen species. We studied the genes MnSOD and 
CuZnSOD in the presence of live/dead V. gazogenes cells at the 24 h, 30 h and 40 h time 
points of A. flavus growth (figure 5.11). The 30 h and 40 h samples were compared to the 
24 h sample of that specific treatment condition. The CuZnSOD gene expression was 
decreased as compared to its specific control during both live and dead V. gazogenes 
treatments. This is similar to the already existing data stating the decrease in CuZnSOD 
from 24 h to 40 h. The MnSOD gene expression increased as compared to its specific 
control during both live and dead V. gazogenes treatments following the same pattern as 
untreated control samples. The only difference was that in the live V. gazogenes 
treatments the increase in MnSOD over time is double as compared to the untreated 
controls. Keene et al propose a model for aflatoxin biosynthesis protecting the cells 
against the toxic effects of ROS (Keene et al., 2018). Therefore more aflatoxin means 
less ROS. Thus the increase in MnSOD in presence of live V. gazogenes cells might be 
hypothesized that there might be increased levels of ROS as the aflatoxin levels had been 
all but completely inhibited. 
5.4.11 V. gazogenes decreases aflatoxin in corn and delays infestation of corn by A. 
flavus 
A. flavus effects plant health and crop produce by not only producing the 
mycotoxin aflatoxin but also by acting as a pathogen. Data already showed the aflatoxin 
inhibitory effects of V. gazogenes so now we would like to understand the effects of V. 
gazogenes on A. flavus pathogenicity. We pricked corn kernels to mimic insect bites 
since it was proved that insect bites make the corn more susceptible to A. flavus 
infestations (Cardwell et al., 2000). Three sets of 10-kernels/each set were used and data 
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was shown in figure 5.12 where the top panel shows pictures of kernels taken using Leica 
dissection microscope. The kernels having no A. flavus or V. gazogenes did not have any 
bacterial or fungal contamination. The positive controls for V. gazogenes did not have 
any fungal contamination or bacterial infestation suggesting that V. gazogenes might not 
be a plant pathogen. The positive controls for A. flavus had plenty of mycelial growth and 
spore generation proving the already known fact that A. flavus infests maize. The kernels 
treated with live V. gazogenes cells prior to A. flavus infestation showed only 20% 
conidial formation, which is almost 80% less than A. flavus positive controls. The 
aflatoxin production in the V. gazogenes treated kernels was <98% as compared to the 
positive controls. These data show that V. gazogenes has a high possibility to become 
anti-A. flavus pesticide for plants. 
5.4.12 V. gazogenes increases survival of Drosophila flies infected with A. flavus 
Drosophila melanogaster is a well-studied and well-established model organism 
for understanding human diseases. Here we used the common fruit fly as a model to 
study the effects of V. gazogenes on A. flavus human pathogen. We used atleast 25 
flies/tube of 3 sets per condition and data was shown in figure 5.13. Drosophila flies with 
no A. flavus or V. gazogenes had survival of 100% at the end of 7 days. Drosophila flies 
with only V. gazogenes also had survival of 100% at the end of 7 days suggesting that V. 
gazogenes might not be a Drosophila fly pathogen. The positive controls with Drosophila 
having infected with only A. flavus had survival of 0 at the end of 8 days since all flies 
died. Surprisingly the flies treated with V. gazogenes in their feed and then infected with 
A. flavus had survival of 40% at the end of 7 days. Finally we studied the pathogenic 
gene SAP (serine alanine protease) since it was considered as a marker for A. flavus 
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pathogenicity. In the untreated samples SAP gene expression increased at 40 h but in live 
V. gazogenes treated samples the SAP gene expression increase early on at 30 h and 
maintain high through 40 h. The dead V. gazogenes cell treatments to not effect SAP 
gene expression as compared to their control at 24 h. The data show that V. gazogenes 
increase survival in Drosophila during A. flavus infections and the mechanism of action 
might not be at the gene level. 
5.5 DISCUSSION 
This research study shows the discovery of a novel tool (Vibrio gazogenes) to 
inhibit aflatoxin production and pathogenicity of human and plant pathogen Aspergillus 
flavus. Researchers had previously shown the inhibition of aflatoxin production in A. 
flavus or a close sister species A. parasiticus by lactic acid bacteria such as Lactobacillus 
casei (Chang and Kim 2007), gram positive bacteria such as Bacillus subtilis (Farzaneh et 
al., 2017) and other soil bacteria. Most studies show a decrease in aflatoxin levels and the 
mechanism of action of the bacterium was primarily by inhibiting the aflatoxin 
biosynthesis pathway genes. Here for the first time we use a marine bacterium V. 
gazogenes and the mechanism of aflatoxin inhibition was not at the gene level (we 
observe an increase in aflatoxin and secondary metabolite regulatory genes) but at the 
cellular level thereby breaking the previously established paradigm. 
Both viable and unviable V. gazogenes cells inhibition of aflatoxin is >98% with 
out effecting the growth of A. flavus in both solid and liquid growth medium. On the 
other hand live V. gazogenes cells significantly increase spore production of A. flavus on 
classical potato dextrose media. Spores are the means by which the fungi disperse and 
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find new and favorable environment to grow and flourish on. The second-generation 
spores generated due to A. flavus treatment with V. gazogenes carried over the aflatoxin 
inhibition properties and consequently decreased aflatoxin by 40%. It is new to know that 
the V. gazogenes aflatoxin inhibitory effects can transcend generations. 
The gene data of A. flavus of various genes up- and down- regulated in the 
presence of live and dead V. gazogenes does not follow the same pattern. This leads us to 
conclude that live and dead V. gazogenes cells do not follow the same mechanism of 
aflatoxin inhibition in A. flavus. V. gazogenes were made nonviable or dead by heating 
which causes protein denaturation but might not break the structural integrity of the 
peptidoglycan structure of the bacterial cell wall (Carolyn A. Haskard, et al., 2001). 
Lactic acid bacteria made nonviable by heating effectively removed aflatoxin B1 from 
the media suggesting binding rather than metabolism (Carolyn A. Haskard et al., 2001). 
Therefore the dead V. gazogenes might be removing aflatoxin from media via cell wall 
binding. 
The aflatoxin inhibition by live V. gazogenes was through the uptake of the live 
bacterium by fungus into endosomal like compartments, which we had observed using 
confocal, SEM and TEM microscopies. Previously published data show the 
internalization of the bacteria via endocytosis like mechanism (Guerra-Tschuschke et al., 
1991). Anindya et al isolated protoplasts and performed feeding experiments concluding 
that aflatoxin synthesis was happening in vesicles termed aflatoxisomes, which are 
endosomal like compartments (Chanda et al., 2009). Thus we suggest that live V. 
gazogenes cells were entering the A. flavus through endocytosis like mechanism (into 
endocytosis like compartments) probably into the aflatoxisomes (that contains all the 
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enzymes required for aflatoxin synthesis) and inhibiting the aflatoxin biosynthesis at the 
cellular level. Researchers propose that during the fungal growth, a shift in the media 
components might activate the hydrolase and laccase enzymes, which have the capacity 
to degrade the lactone ring of the aflatoxin (Fatemeh Siahmoshteh et al., 2016). 
Considering the existing data we hypothesize that live V. gazogenes cells might be 
degrading the aflatoxin in the aflatoxisome. Since there was no aflatoxin released into the 
growth media during live V. gazogenes treatments (undetected using ELISA) but an 
increase in aflatoxin pathway genes was observed we predict that the fungal cells were 
making increased transcript to generate more aflatoxin in the fungal cells. 
The relationship between the live V. gazogenes and A. flavus is not conclusive 
from the data obtained. Further experimentation is required to determine the symbiotic 
relationship’s existence and nature between the two microorganisms. We do not yet know 
if the bacterium is still viable inside the fungus. Bacteria are hard to kill and as such there 
is a strong possibility for bacterial-fungal interaction within the fungal cell. 
Understanding the mechanism by which V. gazogenes decreases aflatoxin and 
inhibits pathogenicity of A. flavus will help us further understand how to develop, design 
and target A. flavus pathogen and decrease mortality rates of fungal infected patients and 
plants. This research establishes a novel concept for combating Aspergillosis infections 
that are very common in homes impacted by weather events such as hurricanes and are 
common in immunocompromised individuals (Krishnan et al., 2009). Finally 
polymicrobial (bacterial and fungal) colonies pose a potential problem in clinical setting 
given their multi-drug resistance capabilities. This study has initiated a novel research 
direction that can elucidate the molecular details that regulate bacterial uptake in fungal 
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pathogens. Such interactions are critical in designing probiotic supplements for 
preventing release of virulence factors and secondary metabolites that are key in fungal 
pathogenesis. 
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Table 5.1: List of primers used in this study. 
 
Genes Primer Sequences 
aflR F 5’-ACCTCATGCTCATACCGAGG-3’ 
R 5’-GAAGACAGGGTGCTTTGCTC-3’ 
nor-1 F 5’-CACTTAGCCAGCACGATCAA-3’ 
R 5’-ATGATCATCCGACTGCCTTC-3’ 
ver-1 F 5’-AACACTCGTGGCCAGTTCTT-3’ 
R 5’-ATATACTCCCGCGACACAGC-3’ 
AtfB F 5’-CCGGTTTCGTGAGGTATCCA-3’ 
R 5’-GCATGGGAGAAACCAGATCG-3’ 
laeA F 5’-ATGGGGTGTGGAAGTGTGAT-3’ 
R 5’-ATCGGTAAAACCAGCCTCCT-3’ 
veA F 5’-TCCAGCTATCCCAAGAATGG-3’ 
R 5’-TAATCCCCCGATAGAGCCTT-3’ 
MnSOD F 5’-CCACATCAACCACTCCCTCT-3’ 
R 5’-TCCTGATCCTTCGTCGAAAC-3’ 
CuZnSOD-1 F 5’-CACCAGTTCGGTGACAACAC-3’ 
R 5’-GTGTTCACTACGGCCAAGGT-3’ 
18s F 5’-GCTGAAAACCTCGACTTCGG-3’ 
R 5’-CCTAATTCCCCGTTACCCGT-3’ 
Tubulin F 5’-TCTCCAAGATCCGTGAGGAG-3’ 
R 5’-TTCAGGTCACCGTAAGAGGG-3’ 
SAP F 5’-GAATTCTCGTGGACGTAGCG-3’ 
R 5’-GACGTCGGTCCTTCTTCTCC-3’ 
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Table 5.2: Data of Aflatoxin B1, Aflatoxin B2 and Cyclopiazonic acid obtained from 
UPLC 
 
Sample Aflatoxin B1 
ppb (ng/g mycelia) 
Aflatoxin B2 
ppb (ng/g mycelia) 
Cyclopiazonic acid 
ppb (ng/g mycelia) 
A. flavus 
(no V. gazogenes) 
24.51 3.27 7298.41 
A. flavus + 16 million 
live V. gazogenes 
cells 
0 0 0 
A. flavus + 16 million 
dead V. gazogenes 
cells 
0 0 0 
 
 
 92 
 
 
Figure 5.1: Effect of V. gazogenes on aflatoxin biosynthesis and growth of A. flavus 
mycelial growth: a) & b) A. flavus co-cultured with 4 and 16 million V. gazogenes cells in 
YES liquid media and the dry weight of fungal mycelia was measured and aflatoxin 
levels analyzed after 48 h of incubation. The percentage of A. flavus mycelial weight was 
calculated and plotted on y-axis. Bars represent measurements relative to the dry weight 
of untreated (a). Percent aflatoxin accumulation in media of 48 h cultures (b). p-value 
<0.01 and n=3 c)&d) A. flavus co-cultured with V. gazogenes on YES agar media plates 
and the colony growth was measured and the aflatoxin was analyzed after 9 days of 
incubation. The growth of fungal colony in cm was measured and plotted on y-axis (c) 
(n=2). Percent aflatoxin accumulation in agar media of the fungal colonies was plotted 
(d) (n=4). p-value <0.01. Statistical significance of two-tailed p-values were determined 
using an unpaired t-test. Error-bars represent SEM. Star indicates significance. 
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Figure 5.2: Effect of V. gazogenes on A. flavus aflatoxin production over time: A. flavus 
was co-cultured with 16 million V. gazogenes cells in YES liquid media and the mycelial 
growth of fungus was calculated and aflatoxin analyzed at 24, 48 and 72 h. a) Dry weight 
of mycelia was plotted on y-axis and bars represent the measurements in grams. b) 
Percentage of aflatoxin was plotted on y-axis considering no treated (C) 72 h control 
aflatoxin levels as 100% and the aflatoxin in rest of samples plotted relative to the 72 h C. 
Insert shows the accumulation of aflatoxin at 48 h. p-value <0.01. Statistical significance 
of two-tailed p-values were determined using an unpaired t-test for n=3. Error-bars 
represent SEM. Star indicates significance. 
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Figure 5.3: A) Effect of V. gazogenes on A. flavus spore generation: A. flavus was co-
cultured with V. gazogenes on 10cm PDA media plates and the colony growth was 
measured and the aflatoxin was analyzed after 9 days of incubation. i) The growth of 
fungal colony in cm was measured and plotted on y-axis. ii) The bars represent percent 
aflatoxin accumulation in agar media of the fungal colonies as compared to the untreated 
control. iii) Percent of spores per colony was counted and plotted with the bars 
representing the number of spores as compared to the untreated control (n=4). B) Activity 
of second-generation A. flavus spores. Spores generated from bacterial treatment were re-
plated on fresh PDA plates (without V. gazogenes) and colony growth was observed for 9 
days. i) The growth of fungal colony in cm was measured and plotted on y-axis. ii) The 
bars represent percent aflatoxin accumulation in agar media of the fungal colonies as 
compared to the untreated control. iii) Percent of spores per colony was counted and 
plotted with the bars representing the number of spores as compared to the untreated 
control (n=2). Statistical significance of two-tailed p-values were determined using an 
unpaired t-test. Error-bars represent SEM. Star indicates significance. 
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Figure 5.4: Effect of dead V. gazogenes cells on A. flavus growth and aflatoxin 
production: A. flavus co-cultured with dead 4 and 16 million V. gazogenes cells in YES 
liquid media and the dry weight of fungal mycelia was measured and aflatoxin levels 
analyzed after 48 h of incubation. a) The percentage of A. flavus mycelial weight was 
calculated and plotted on y-axis. Bars represent measurements relative to the dry weight 
of untreated. b) Percent aflatoxin accumulation in media of 48 h cultures. p-value <0.01 
and n=2. Statistical significance of two-tailed p-values were determined using an 
unpaired t-test for n=3. Error-bars represent SEM. Star indicates significance. 
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Figure 5.5: Effect of dead S. aureus and E. coli on A. flavus growth and aflatoxin 
production: A. flavus co-cultured with dead 16 million S. aureus and E. coli cells in YES 
liquid media and the dry weight of fungal mycelia was measured and aflatoxin levels 
analyzed after 72 h of incubation. a) The percentage of A. flavus mycelial weight was 
calculated and plotted on y-axis. Bars represent measurements relative to the dry weight 
of untreated. b) Percent aflatoxin accumulation in media of 48 h cultures. p-value <0.01 
and n=2. Statistical significance of two-tailed p-values were determined using an 
unpaired t-test for n=2 revealing that there was no statistical difference between control 
and treated samples. Error-bars represent SEM. 
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Figure 5.6: Uptake of V. gazogenes by A. flavus: a) V. gazogenes and A. flavus were co-
cultured in YES liquid media. Every 6 h the OD of the bacteria at 600 nm was measured 
and plotted on y-axis with incubation time in the x-axis (n=3). b) The confocal 
microscopy of A. flavus hyphae in the presence of V. gazogenes at 20x magnification. 
This is a representation of n=3 experiments. 
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Figure 5.7: V. gazogenes increases aflatoxin pathway genes: Quantitative PCR (qPCR) 
comparison of aflatoxin pathway gene (aflR, nor-1, ver-1) expressions in A. flavus during 
the two treatment conditions of live and dead V. gazogenes at 24 h, 30 h and 40 h time 
points of culture growth. Each individual gene expression was normalized to the 
housekeeping gene 18s which was used as reference gene. The 30 h and 40 h samples 
were compared to the 24 h sample of that specific treatment condition to calculate 
relative fold change in gene expressions. Fold changes ≥2.0 with p-value <0.01 were 
considered significantly up or down regulated. Star indicates statistically significant fold 
change as compared to the 24 h control of that specific treatment. 
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Figure 5.8: V. gazogenes increases global secondary metabolite regulatory genes: 
Quantitative PCR (qPCR) comparison of global secondary metabolite regulate (AtfB, 
laeA, veA) gene expression in A. flavus during the two treatment condition of live and 
dead V. gazogenes at 24 h, 30 h and 40 h time points of culture growth. Each individual 
gene expression was normalized to the housekeeping gene 18s which was used as 
reference gene. The 30 h and 40 h samples were compared to the 24 h sample of that 
specific treatment condition to calculate relative fold change in gene expressions. Fold 
changes ≥2.0 with p-value <0.01 were considered significantly up or down regulated. 
Star indicates statistically significant fold change as compared to the 24 h control of that 
specific treatment. 
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Figure 5.9: Scanning electron microscopy of A. flavus uptake of V. gazogenes: Scanning 
electron microscopy of A. flavus hyphae treated with V. gazogenes at 17k magnification. 
The top left image is of control hypha and the left bottom image is of A. flavus in 
presence of V. gazogenes. The magnified image is of a hypha with arrows pointing to the 
bacteria being endocytosed. The scale is 5 µm. 
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Figure 5.10: Transmission electron microscopy of A. flavus uptake of V. gazogenes: 
Transmission electron microscope’s cross sectional images of untreated control A. flavus 
hyphae (top images) and V. gazogenes treated hyphae (bottom images) with 10k 
magnification (left images) and 20k magnification (right images). The arrows point to 
endosomal compartments. This is a representation of n=3 experiments. 
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Figure 5.11: V. gazogenes increases SOD genes: Quantitative PCR (qPCR) comparison 
of SOD gene expression in A. flavus during the two treatment condition of live and dead 
V. gazogenes at 24 h, 30 h and 40 h time points of culture growth. Each individual gene 
expression was normalized to the housekeeping gene 18s which was used as reference 
gene. The 30 h and 40 h samples were compared to the 24 h sample of that specific 
treatment condition to calculate relative fold change in gene expressions. Fold changes 
≥2.0 with p-value <0.01 were considered significantly up or down regulated. Star 
indicates statistically significant fold change as compared to the 24 h control of that 
specific treatment. 
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Figure 5.12: Effect of V. gazogenes on corn infestation of A. flavus: Packaged corn 
kernels were used with 10-kernels/treatment set and the sets were done in triplicate. 
Control (C) was a negative control with no A. flavus or V. gazogenes. V. gazogenes (Vg) 
was a positive control for the bacteria having only V. gazogenes. A. flavus (Af) was a 
positive control for the fungus having only A. flavus. A. flavus + V. gazogenes (Af+Vg) 
was the treatment condition where kernel was infested with A. flavus in the presence of V. 
gazogenes. a) The top panel shows images taken using Leica dissection microscope on 
the 5th day on incubation. b) The graph represents the percent of conidia/spores formation 
on the corn kernels in the presence and absence of V. gazogenes during A. flavus 
infestation. c) The bars represent the percentage of aflatoxin present in the kernels as 
compared to the A. flavus positive control (Af). p-value <0.01. Statistical significance of 
two-tailed p-values were determined using an unpaired t-test for n=3. Error-bars represent 
SEM. Star represents the difference as compared to the control was statistically 
significant. 
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Figure 5.13: Effect of V. gazogenes on Drosophila infection by A. flavus: a) Drosophila 
melanogaster flies were infected with A. flavus in the absence (Af) and presence (Af+Vg) 
of live V. gazogenes cells. We used 3-5 day old female flies, 25 flies/tube (for Af) and 29 
flies/tube (for Af+Vg) in sets of 3 (method was describes earlier). The percentage of flies 
survived per day per tube was calculated and plotted as a line graph. b) Quantitative PCR 
(qPCR) comparison of SAP (pathogenic gene) gene expression in A. flavus during the 
two treatment 2condition of live and dead V. gazogenes at 24 h, 30 h and 40 h time points 
of culture growth. The gene expression was normalized to the housekeeping gene 18s 
which was used as reference gene. The 30 h and 40 h samples were compared to the 24 h 
sample of that specific treatment condition to calculate relative fold change in gene 
expressions. Fold changes ≥2.0 with p-value <0.01 were considered significantly up or 
down regulated. Star indicates statistically significant fold change as compared to the 24 
h control of that specific treatment. 
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